Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-let-7g-3p ABL2 -1.14 0 0.6 0 mirMAP -0.12 0.00068 NA
2 hsa-miR-125b-5p ABL2 -1.36 0 0.6 0 MirTarget -0.17 0 NA
3 hsa-miR-139-5p ABL2 -2.11 0 0.6 0 miRanda -0.12 0 NA
4 hsa-miR-192-3p ABL2 -0.64 0.00027 0.6 0 MirTarget -0.13 0 NA
5 hsa-miR-26b-5p ABL2 -1.11 0 0.6 0 MirTarget; miRNATAP -0.12 0.0024 NA
6 hsa-miR-29a-3p ABL2 -0.86 0 0.6 0 mirMAP -0.13 0.00048 NA
7 hsa-miR-29b-3p ABL2 -0.35 0.01214 0.6 0 mirMAP -0.11 0.00139 NA
8 hsa-miR-30e-3p ABL2 -1.21 0 0.6 0 mirMAP -0.19 0 NA
9 hsa-miR-30e-5p ABL2 -0.63 0 0.6 0 mirMAP -0.18 5.0E-5 NA
10 hsa-miR-378a-3p ABL2 -1.19 0 0.6 0 mirMAP -0.19 0 NA
11 hsa-miR-378c ABL2 -1.54 0 0.6 0 mirMAP -0.21 0 NA
12 hsa-miR-505-3p ABL2 -1.2 0 0.6 0 miRNATAP -0.18 0 NA
13 hsa-miR-576-5p ABL2 -0.38 0.00471 0.6 0 mirMAP -0.12 0.00026 NA
14 hsa-miR-21-5p AKT2 1.51 0 -0.34 1.0E-5 miRNAWalker2 validate -0.25 0 NA
15 hsa-miR-330-5p AKT2 0.44 0.00533 -0.34 1.0E-5 miRanda -0.1 1.0E-5 NA
16 hsa-miR-342-3p AKT2 -0.32 0.04498 -0.34 1.0E-5 mirMAP -0.12 0 NA
17 hsa-miR-106b-5p AKT3 0.65 0 -0.66 0.00047 miRNATAP -0.26 0.00148 NA
18 hsa-miR-107 AKT3 0.24 0.01708 -0.66 0.00047 PITA; miRanda -0.6 0 NA
19 hsa-miR-122-5p AKT3 -1.24 0 -0.66 0.00047 miRNAWalker2 validate; miRTarBase -0.28 0 24244539 miR 122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3; Here we identify AKT3 as a novel and direct target of miR-122; Restoration of miR-122 expression in HCC cell lines decreases AKT3 levels inhibits cell migration and proliferation and induces apoptosis; These anti-tumor phenotypes can be rescued by reconstitution of AKT3 expression indicating the essential role of AKT3 in miR-122 mediated HCC transformation; Our data strongly suggest that miR-122 is a tumor suppressor that targets AKT3 to regulate tumorigenesis in HCCs and a potential therapeutic candidate for liver cancer
20 hsa-miR-146b-5p AKT3 0.42 0.04574 -0.66 0.00047 miRNAWalker2 validate -0.16 0.00026 NA
21 hsa-miR-15a-5p AKT3 0.35 0.00077 -0.66 0.00047 miRNAWalker2 validate; miRTarBase; miRNATAP -0.27 0.00291 NA
22 hsa-miR-17-3p AKT3 0.41 0.00422 -0.66 0.00047 miRNATAP -0.35 0 NA
23 hsa-miR-17-5p AKT3 0.7 2.0E-5 -0.66 0.00047 TargetScan; miRNATAP -0.29 0 NA
24 hsa-miR-20a-5p AKT3 0.85 0 -0.66 0.00047 miRNATAP -0.29 0 NA
25 hsa-miR-32-3p AKT3 0.22 0.20722 -0.66 0.00047 mirMAP -0.23 4.0E-5 NA
26 hsa-miR-33a-3p AKT3 -0.68 1.0E-5 -0.66 0.00047 mirMAP -0.23 0.0001 NA
27 hsa-miR-362-3p AKT3 0.81 0 -0.66 0.00047 miRanda -0.22 0.00083 NA
28 hsa-miR-362-5p AKT3 0.72 2.0E-5 -0.66 0.00047 PITA; TargetScan; miRNATAP -0.15 0.00734 NA
29 hsa-miR-374a-5p AKT3 0.02 0.86978 -0.66 0.00047 mirMAP -0.28 0.00294 NA
30 hsa-miR-502-3p AKT3 0.66 0 -0.66 0.00047 miRNATAP -0.26 0.0008 NA
31 hsa-miR-616-5p AKT3 0.15 0.40284 -0.66 0.00047 mirMAP -0.2 0.0001 NA
32 hsa-miR-93-5p AKT3 1.4 0 -0.66 0.00047 miRNATAP -0.28 1.0E-5 NA
33 hsa-miR-125a-5p ANGPT2 -0.91 0 1.15 0 miRanda -0.16 0.002 NA
34 hsa-miR-142-5p ANGPT2 -1.45 0 1.15 0 MirTarget -0.18 0.00013 NA
35 hsa-miR-145-5p ANGPT2 -1.48 0 1.15 0 MirTarget; miRNATAP -0.2 6.0E-5 24384875; 27570490 miR 145 functions as tumor suppressor and targets two oncogenes ANGPT2 and NEDD9 in renal cell carcinoma; We further validated those miR-145 targets two oncogenes ANGPT2 and NEDD9 in RCC;MiR 145 functions as a tumor suppressor via regulating angiopoietin 2 in pancreatic cancer cells; The direct action of miR-145 on Ang-2 was predicted by TargetScan and confirmed by luciferase report assay; The expression level of miR-145 was significantly lower and the expression levels of Ang-2 mRNA and protein was significantly higher in the more aggressive pancreatic cancer cells MiaPaCa-2 and Panc-1 when compared to that in BxPC3 cells; Overexpression of miR-145 in the BxPC3 MiaPaCa-2 and Panc-1 cells suppressed the cell invasion and colony formation ability and the expression level of Ang-2 protein in MiaPaCa-2 and Panc-1 cells was also suppressed after pre-miR-145 transfection; Intratumoral delivery of miR-145 inhibited the growth of pancreatic cancer xenografts and angiogenesis in vivo and also suppressed the expression level of angiopoietin-2 protein; MiR-145 functions as a tumor suppressor in pancreatic cancer cells by targeting Ang-2 for translation repression and thus suppresses pancreatic cancer cell invasion and growth which suggests that restoring of miR-145 may be a potential therapeutic target for pancreatic cancer
36 hsa-miR-335-3p ANGPT2 -0.28 0.10663 1.15 0 mirMAP -0.16 0.00304 NA
37 hsa-miR-429 ANGPT2 -1.4 7.0E-5 1.15 0 miRanda -0.1 0.00014 NA
38 hsa-miR-542-3p ANGPT2 -1.31 0 1.15 0 MirTarget; miRanda; miRNATAP -0.36 0 NA
39 hsa-miR-744-3p ANGPT2 -0.87 0 1.15 0 MirTarget -0.15 0.00937 NA
40 hsa-miR-330-5p BCL2L1 0.44 0.00533 0.02 0.82745 PITA; miRanda; miRNATAP -0.15 0 NA
41 hsa-miR-342-3p BCL2L1 -0.32 0.04498 0.02 0.82745 PITA; miRanda; miRNATAP -0.12 8.0E-5 NA
42 hsa-miR-342-5p BCL2L1 -0.78 0 0.02 0.82745 miRNATAP -0.11 0.00084 NA
43 hsa-miR-484 BCL2L1 0.09 0.45398 0.02 0.82745 miRNAWalker2 validate -0.21 0 NA
44 hsa-miR-107 BDNF 0.24 0.01708 0.05 0.83189 MirTarget; PITA; miRanda; miRNATAP -0.55 0 27498977 MicroRNA 107 inhibits tumor growth and metastasis by targeting the BDNF mediated PI3K/AKT pathway in human non small lung cancer; In addition BDNF expression was upregulated and inversely correlated with miR-107 in NSCLC tissues; Enforced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-107 on NSCLC proliferation migration and invasion; miR-107 overexpression or downregulation of BDNF was able to inhibit activation of PI3K/AKT signaling pathway; Taken together our findings present the first evidence that miR-107 could suppress NSCLC metastasis by targeting BDNF and indirectly regulating PI3K/AKT signaling pathway which might lead to a potential therapeutic strategy focusing on miR-107 and BDNF for human NSCLC
45 hsa-miR-148a-5p BDNF -0.77 0 0.05 0.83189 mirMAP -0.26 0.00044 NA
46 hsa-miR-192-3p BDNF -0.64 0.00027 0.05 0.83189 MirTarget; miRNATAP -0.32 0 NA
47 hsa-miR-30d-5p BDNF 0.72 0 0.05 0.83189 miRNATAP -0.3 0.00095 NA
48 hsa-miR-589-5p BDNF 1.19 0 0.05 0.83189 miRNATAP -0.24 0.00999 NA
49 hsa-miR-186-5p CALM1 -0.06 0.53529 -0.58 0 mirMAP -0.12 0.00256 NA
50 hsa-miR-423-5p CALM1 0.7 0 -0.58 0 miRNATAP -0.22 0 NA
51 hsa-miR-27a-3p CALM3 -0.37 0.00876 0.21 0.01527 miRNATAP -0.1 0.00043 NA
52 hsa-miR-27b-3p CALM3 -0.82 0 0.21 0.01527 miRNAWalker2 validate; miRNATAP -0.11 0.00372 NA
53 hsa-miR-29a-3p CALM3 -0.86 0 0.21 0.01527 miRNATAP -0.11 0.00125 NA
54 hsa-miR-106a-5p CALML4 -0.46 0.00972 0.01 0.91319 mirMAP -0.11 0.0004 NA
55 hsa-miR-148b-5p CALML4 0.3 0.02557 0.01 0.91319 mirMAP -0.11 0.00714 NA
56 hsa-miR-330-3p CALML4 -0.33 0.03161 0.01 0.91319 miRNATAP -0.12 0.00141 NA
57 hsa-miR-500a-5p CALML4 0.8 0 0.01 0.91319 mirMAP -0.13 0.00022 NA
58 hsa-miR-7-1-3p CALML4 -0.57 2.0E-5 0.01 0.91319 mirMAP -0.12 0.0035 NA
59 hsa-miR-15a-5p CHUK 0.35 0.00077 -0.2 0.00863 miRNAWalker2 validate; miRTarBase; MirTarget -0.12 0.00057 NA
60 hsa-miR-15b-5p CHUK 0.23 0.08248 -0.2 0.00863 MirTarget -0.12 2.0E-5 NA
61 hsa-miR-16-5p CHUK -0.4 0.0001 -0.2 0.00863 miRNAWalker2 validate; miRTarBase; MirTarget -0.15 3.0E-5 NA
62 hsa-miR-23a-3p CHUK -0.18 0.13598 -0.2 0.00863 MirTarget -0.1 0.00114 NA
63 hsa-miR-339-5p CHUK 0.28 0.03557 -0.2 0.00863 miRanda -0.12 1.0E-5 NA
64 hsa-miR-590-5p CHUK -0.1 0.31003 -0.2 0.00863 miRanda -0.12 0.00129 NA
65 hsa-miR-107 CSF1 0.24 0.01708 -0.59 0.00153 miRanda -0.29 0.00148 NA
66 hsa-miR-148a-3p CSF1 -0.75 0 -0.59 0.00153 miRNATAP -0.26 2.0E-5 NA
67 hsa-miR-17-5p CSF1 0.7 2.0E-5 -0.59 0.00153 TargetScan; miRNATAP -0.24 1.0E-5 NA
68 hsa-miR-20a-5p CSF1 0.85 0 -0.59 0.00153 miRNATAP -0.28 0 NA
69 hsa-miR-93-5p CSF1 1.4 0 -0.59 0.00153 miRNATAP -0.22 0.00049 NA
70 hsa-miR-107 CSF1R 0.24 0.01708 -1.23 0 miRanda -0.45 0 NA
71 hsa-miR-30c-2-3p EFNA1 -1.4 0 0.65 4.0E-5 MirTarget -0.23 0 NA
72 hsa-miR-326 EFNA1 -1.88 0 0.65 4.0E-5 miRanda -0.14 0.00016 NA
73 hsa-miR-486-5p EFNA1 -1.78 0 0.65 4.0E-5 miRanda -0.15 0 NA
74 hsa-miR-145-5p EFNA3 -1.48 0 1.75 0 miRNATAP -0.28 0 NA
75 hsa-miR-27b-3p EFNA3 -0.82 0 1.75 0 miRNATAP -0.58 0 NA
76 hsa-miR-30a-5p EFNA3 -0.63 0.00011 1.75 0 MirTarget; mirMAP; miRNATAP -0.32 0 NA
77 hsa-miR-30c-5p EFNA3 -0.43 0.00016 1.75 0 MirTarget; mirMAP; miRNATAP -0.27 0.00277 NA
78 hsa-miR-30e-5p EFNA3 -0.63 0 1.75 0 MirTarget; mirMAP -0.49 0 NA
79 hsa-miR-326 EFNA3 -1.88 0 1.75 0 MirTarget; miRanda; miRNATAP -0.18 0.00048 NA
80 hsa-miR-342-5p EFNA3 -0.78 0 1.75 0 miRNATAP -0.19 0.0034 NA
81 hsa-miR-3607-3p EFNA3 -2.16 0 1.75 0 mirMAP; miRNATAP -0.2 1.0E-5 NA
82 hsa-miR-486-5p EFNA3 -1.78 0 1.75 0 miRanda -0.22 0 NA
83 hsa-miR-1976 EFNA4 -0.43 0.00325 1.48 0 MirTarget -0.18 0.00019 NA
84 hsa-miR-26b-5p EFNA4 -1.11 0 1.48 0 miRNAWalker2 validate -0.35 0 NA
85 hsa-miR-101-3p EFNA5 -1.48 0 -1.36 0.00069 miRNATAP -0.63 1.0E-5 NA
86 hsa-miR-1269a EFNA5 3.58 0 -1.36 0.00069 mirMAP -0.12 0.00012 NA
87 hsa-miR-19a-3p EFNA5 1.02 0 -1.36 0.00069 miRNATAP -0.28 0.00424 NA
88 hsa-miR-19b-3p EFNA5 0.6 0.00017 -1.36 0.00069 miRNATAP -0.4 0.00089 NA
89 hsa-miR-204-5p EFNA5 -0.54 0.03309 -1.36 0.00069 miRNATAP -0.39 0 NA
90 hsa-miR-28-5p EFNA5 -0.43 0 -1.36 0.00069 PITA; miRNATAP -0.96 1.0E-5 NA
91 hsa-miR-32-3p EFNA5 0.22 0.20722 -1.36 0.00069 mirMAP -0.4 0.00061 NA
92 hsa-miR-362-3p EFNA5 0.81 0 -1.36 0.00069 miRanda -0.41 0.0042 NA
93 hsa-miR-378a-3p EFNA5 -1.19 0 -1.36 0.00069 miRNATAP -0.37 0.00023 NA
94 hsa-miR-378c EFNA5 -1.54 0 -1.36 0.00069 miRNATAP -0.26 0.00742 NA
95 hsa-miR-92a-3p EFNA5 0.21 0.13429 -1.36 0.00069 miRNAWalker2 validate -0.49 0.00038 NA
96 hsa-miR-146a-5p EGFR -0.74 0.00077 -1.02 0 miRNAWalker2 validate -0.22 0 24895573; 25242818; 22161865; 25596948; 25417703; 23555954; 24839931; 21632853 Furthermore western blot showed that miR-146a mimic downregulated EGFR ERK1/2 and stat5 signalings; These effects were less potent compared to that of a siRNA targeting EGFR a known target gene of miR-146a; Moreover miR-146a mimic could enhance the cell growth inhibition and apoptosis induction impact of various EGFR targeting agents;Interestingly re-expression of miR-146a inhibited the invasive capacity of Colo357 and Panc-1 PC cells with concomitant down-regulation of EGFR and IRAK-1; Most importantly we found that the treatment of PC cells with "natural agents" 33'-diinodolylmethane DIM or isoflavone led to an increase in the expression of miR-146a and consequently down-regulated the expression of EGFR MTA-2 IRAK-1 and NF-κB resulting in the inhibition of invasion of Colo357 and Panc-1 cells;MiR 146a suppresses tumor growth and progression by targeting EGFR pathway and in a p ERK dependent manner in castration resistant prostate cancer; Mechanistic studies revealed that miR-146a repressed the expression of EGFR through binding to its 3'-untranslated region; Our findings suggest that ubiquitous loss of miR-146a is a critical mechanism for overexpression of EGFR in CRPC which is crucial to better understanding the pathogenesis of CRPC;Furthermore the expressions of bax and cleaved-caspase-3 mainly were increased in control and overexpression miR-146a groups however the expression of EGFR was inverse; All the results demonstrated that quercetin exhibited excellent effect on inhibiting cell proliferation in human breast cancer cells which was performed by up-regulating miR-146a expression then via inducing apoptosis through caspase-3 activation and mitochondrial-dependent pathways and inhibiting invasion through down-regulating the expression of EGFR;Here we report a previously unrecognized posttranscriptional mechanism by which BRCA1 regulates EGFR expression through the induction of miR-146a; We show that BRCA1 binds to MIR146A promoter and activates transcription which in turn attenuates EGFR expression;In functional experiments miR-146a suppressed cell growth induced cellular apoptosis and inhibited EGFR downstream signaling in five NSCLC cell lines H358 H1650 H1975 HCC827 and H292 miR-146a also inhibited the migratory capacity of these NSCLC cells; On the other hand miR-146a enhanced the inhibition of cell proliferation by drugs targeting EGFR including both TKIs gefitinib erlotinib and afatinib and a monoclonal antibody cetuximab; Our results suggest that these effects of miR-146a are due to its targeting of EGFR and NF-κB signaling;Deregulation of miR 146a expression in a mouse model of pancreatic cancer affecting EGFR signaling; Treatment of PC cells with CDF a novel synthetic compound led to re-expression of miR-146a resulting in the down-regulation of EGFR expression; Further knock-down of miR-146a in AsPC-1 cells led to the up-regulation of EGFR expression and showed increased clonogenic growth; In addition knock-down of EGFR by EGFR siRNA transfection of parental AsPC-1 cells and AsPC-1 cells stably transfected with pre-miR-146a resulted in decreased invasive capacity which was further confirmed by reduced luciferase activity in cells transfected with pMIR-Luc reporter vector containing miR-146a binding site; Collectively these results suggest that the loss of expression of miR-146a is a fundamental mechanism for over-expression of EGFR signaling and that re-expression of miR-146a by CDF treatment could be useful in designing personalized strategy for the treatment of human PC;The regulation of EGFR and IRAK1 by miR-146a was examined with miR-146a-transfected gastric cancer cells; Ectopic expression of miR-146a inhibited migration and invasion and downregulated EGFR and IRAK1 expression in gastric cancer cells; MiR-146a targeting of EGFR and IRAK1 is an independent prognostic factor in gastric cancer cases
97 hsa-miR-146b-5p EGFR 0.42 0.04574 -1.02 0 miRNATAP -0.22 0 NA
98 hsa-miR-148b-5p EGFR 0.3 0.02557 -1.02 0 mirMAP -0.23 0.00227 NA
99 hsa-miR-17-5p EGFR 0.7 2.0E-5 -1.02 0 TargetScan -0.16 0.00764 NA
100 hsa-miR-188-5p EGFR 1.12 0 -1.02 0 mirMAP -0.3 0 NA
101 hsa-miR-21-5p EGFR 1.51 0 -1.02 0 miRNAWalker2 validate; miRTarBase -0.44 0 24198203; 20113523; 24012640; 24331411; 26563758; 19597153; 26026961; 20048743 In radically resected NSCLC patients the expression levels of miR-21 10b in patients with EGFR mutation were much higher than those without mutation;Thus the miR-21 inhibitor might interrupt the activity of EGFR pathways independently of PTEN status;Further the expression of miR-21 is regulated by EGFR via the activation of β-catenin and AP-1; These data indicate that a feedback loop exists between miR-21 and EGFR; These results clarify a novel association between miR-21 and EGFR in the regulation of cancer cell progression;MiR 21 overexpression is associated with acquired resistance of EGFR TKI in non small cell lung cancer;Higher expression levels of miR-21 AmiR-27a and miR-218 detected in this study suggest potential roles of these miRNAs in primary resistance to EGFR-TKI in advanced NSCLC patients with EGFR exon 19 deletion mutations;MiR 21 is an EGFR regulated anti apoptotic factor in lung cancer in never smokers; The changes in expression of some of these miRNAs including miR-21 were more remarkable in cases with EGFR mutations than in those without these mutations; In the never-smoker-derived lung adenocarcinoma cell line H3255 with mutant EGFR and high levels of p-EGFR and miR-21 antisense inhibition of miR-21 enhanced AG1478-induced apoptosis; In a never-smoker-derived adenocarcinoma cell line H441 with wild-type EGFR the antisense miR-21 not only showed the additive effect with AG1478 but also induced apoptosis by itself; These results suggest that aberrantly increased expression of miR-21 which is enhanced further by the activated EGFR signaling pathway plays a significant role in lung carcinogenesis in never-smokers as well as in smokers and is a potential therapeutic target in both EGFR-mutant and wild-type cases;Nickel may contribute to EGFR mutation and synergistically promotes tumor invasion in EGFR mutated lung cancer via nickel induced microRNA 21 expression;Downregulation of miR 21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
102 hsa-miR-29a-5p EGFR -0.11 0.34962 -1.02 0 mirMAP -0.46 0 27477273 Feedback Loop Regulation of SCAP/SREBP 1 by miR 29 Modulates EGFR Signaling Driven Glioblastoma Growth
103 hsa-miR-32-3p EGFR 0.22 0.20722 -1.02 0 mirMAP -0.24 7.0E-5 NA
104 hsa-miR-362-5p EGFR 0.72 2.0E-5 -1.02 0 mirMAP -0.25 3.0E-5 NA
105 hsa-miR-374b-3p EGFR -0.14 0.30532 -1.02 0 mirMAP -0.2 0.00751 NA
106 hsa-miR-455-5p EGFR -0.27 0.05813 -1.02 0 miRanda -0.23 0.00136 NA
107 hsa-miR-501-5p EGFR 1.15 0 -1.02 0 mirMAP -0.23 2.0E-5 NA
108 hsa-miR-590-5p EGFR -0.1 0.31003 -1.02 0 miRanda; mirMAP -0.28 0.00479 NA
109 hsa-miR-769-5p EGFR 0.22 0.03334 -1.02 0 mirMAP -0.5 0 NA
110 hsa-miR-877-5p EGFR 1.36 0 -1.02 0 mirMAP -0.25 0 NA
111 hsa-miR-34a-5p EPHA2 1.04 0 -2.12 0 miRNAWalker2 validate -0.22 0.00193 NA
112 hsa-miR-10b-3p ETS1 2.77 0 -0.89 0 mirMAP -0.11 2.0E-5 NA
113 hsa-miR-1180-3p ETS1 1.14 0 -0.89 0 MirTarget -0.29 0 NA
114 hsa-miR-130b-5p ETS1 0.17 0.33761 -0.89 0 MirTarget -0.12 0.00351 NA
115 hsa-miR-148b-5p ETS1 0.3 0.02557 -0.89 0 MirTarget -0.14 0.00795 NA
116 hsa-miR-193a-3p ETS1 -0.12 0.30939 -0.89 0 miRanda; miRNATAP -0.21 0.00092 NA
117 hsa-miR-221-3p ETS1 1.12 0 -0.89 0 miRTarBase; miRNATAP -0.16 0.00028 21711453 To close the loop we demonstrate ETS-1 as a direct target of miR-222 but not miR-221 showing the novel option of their uncoupled functions
118 hsa-miR-222-3p ETS1 1.09 0 -0.89 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.11 0.00861 21711453 Constitutive activation of the ETS 1 miR 222 circuitry in metastatic melanoma; We demonstrate that the proto-oncogene ETS-1 involved in the pathogenesis of cancers of different origin is a transcriptional regulator of miR-222 by direct binding to its promoter region; Differently from 293FT cells or early stage melanomas where unphosphorylated ETS-1 represses miR-222 transcription in metastatic melanoma the constitutively Thr-38 phosphorylated fraction of ETS-1 induces miR-222; To close the loop we demonstrate ETS-1 as a direct target of miR-222 but not miR-221 showing the novel option of their uncoupled functions
119 hsa-miR-362-3p ETS1 0.81 0 -0.89 0 miRanda -0.18 0.00046 NA
120 hsa-miR-365a-3p ETS1 0.16 0.15325 -0.89 0 MirTarget -0.27 2.0E-5 NA
121 hsa-miR-421 ETS1 0.94 0 -0.89 0 miRanda; mirMAP; miRNATAP -0.2 0 NA
122 hsa-miR-455-5p ETS1 -0.27 0.05813 -0.89 0 MirTarget; PITA; miRanda; miRNATAP -0.23 0 NA
123 hsa-miR-501-5p ETS1 1.15 0 -0.89 0 mirMAP -0.1 0.00735 NA
124 hsa-miR-502-5p ETS1 0.89 0 -0.89 0 miRNATAP -0.11 0.00448 NA
125 hsa-miR-532-3p ETS1 0.3 0.01463 -0.89 0 MirTarget; PITA; miRNATAP -0.29 0 NA
126 hsa-miR-590-5p ETS1 -0.1 0.31003 -0.89 0 miRanda -0.36 0 NA
127 hsa-miR-660-5p ETS1 0.99 0 -0.89 0 MirTarget -0.25 0 NA
128 hsa-miR-769-5p ETS1 0.22 0.03334 -0.89 0 miRNATAP -0.21 0.00233 NA
129 hsa-miR-940 ETS1 0.45 0.01771 -0.89 0 MirTarget; miRNATAP -0.15 7.0E-5 NA
130 hsa-miR-18a-5p ETS2 0.92 2.0E-5 -1.76 0 miRNAWalker2 validate -0.21 0 NA
131 hsa-miR-221-3p ETS2 1.12 0 -1.76 0 miRNATAP -0.36 0 NA
132 hsa-miR-222-3p ETS2 1.09 0 -1.76 0 miRNATAP -0.32 0 NA
133 hsa-miR-30d-5p ETS2 0.72 0 -1.76 0 mirMAP -0.19 0.00162 NA
134 hsa-miR-877-5p ETS2 1.36 0 -1.76 0 miRNAWalker2 validate -0.24 0 NA
135 hsa-miR-25-3p FASLG 0.63 0 -0.79 0.00091 miRNATAP -0.41 0.00032 NA
136 hsa-miR-16-1-3p FGF1 0.39 0.00112 -0.68 0.00654 mirMAP -0.42 3.0E-5 NA
137 hsa-miR-186-5p FGF1 -0.06 0.53529 -0.68 0.00654 mirMAP -0.41 0.00115 NA
138 hsa-miR-18a-5p FGF1 0.92 2.0E-5 -0.68 0.00654 MirTarget -0.26 0 NA
139 hsa-miR-361-5p FGF1 0.23 0.00962 -0.68 0.00654 miRanda -0.51 0.00019 NA
140 hsa-miR-550a-5p FGF1 0.16 0.28251 -0.68 0.00654 MirTarget -0.37 1.0E-5 NA
141 hsa-miR-576-5p FGF1 -0.38 0.00471 -0.68 0.00654 PITA; mirMAP -0.27 0.00357 NA
142 hsa-miR-590-5p FGF1 -0.1 0.31003 -0.68 0.00654 MirTarget; miRanda; miRNATAP -0.47 0.0001 NA
143 hsa-miR-193b-3p FGF11 -0.17 0.27202 0.21 0.27483 miRNAWalker2 validate -0.2 0.00141 NA
144 hsa-miR-28-5p FGF11 -0.43 0 0.21 0.27483 miRanda -0.38 0.00028 NA
145 hsa-miR-548b-3p FGF11 -0.02 0.93082 0.21 0.27483 mirMAP -0.15 0.00025 NA
146 hsa-miR-17-5p FGF12 0.7 2.0E-5 1.13 0.00013 TargetScan -0.35 4.0E-5 NA
147 hsa-miR-200b-3p FGF12 -1.29 0.00027 1.13 0.00013 TargetScan -0.17 3.0E-5 NA
148 hsa-miR-429 FGF12 -1.4 7.0E-5 1.13 0.00013 miRNATAP -0.18 2.0E-5 NA
149 hsa-miR-455-5p FGF12 -0.27 0.05813 1.13 0.00013 miRanda -0.3 0.00353 NA
150 hsa-miR-483-3p FGF12 -2.99 0 1.13 0.00013 PITA -0.12 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 INTRACELLULAR SIGNAL TRANSDUCTION 99 1572 2.604e-73 1.212e-69
2 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 70 498 1.33e-72 3.095e-69
3 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 70 689 1.993e-62 3.091e-59
4 PROTEIN PHOSPHORYLATION 77 944 3.413e-62 3.97e-59
5 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 59 404 3.171e-61 2.951e-58
6 POSITIVE REGULATION OF CATALYTIC ACTIVITY 88 1518 5.311e-60 3.53e-57
7 POSITIVE REGULATION OF MOLECULAR FUNCTION 93 1791 5.151e-60 3.53e-57
8 PHOSPHORYLATION 80 1228 2.541e-57 1.478e-54
9 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 88 1656 8.958e-57 4.632e-54
10 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 93 1977 3.639e-56 1.693e-53
11 POSITIVE REGULATION OF RESPONSE TO STIMULUS 90 1929 1.611e-53 6.816e-51
12 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 67 876 3.518e-51 1.364e-48
13 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 70 1036 4.302e-50 1.43e-47
14 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 70 1036 4.302e-50 1.43e-47
15 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 71 1135 1.316e-48 4.081e-46
16 POSITIVE REGULATION OF MAPK CASCADE 53 470 1.899e-48 5.522e-46
17 POSITIVE REGULATION OF KINASE ACTIVITY 53 482 7.382e-48 2.02e-45
18 REGULATION OF MAPK CASCADE 58 660 4.719e-47 1.22e-44
19 POSITIVE REGULATION OF CELL COMMUNICATION 77 1532 2.048e-46 5.016e-44
20 REGULATION OF PHOSPHORUS METABOLIC PROCESS 77 1618 1.1e-44 2.559e-42
21 REGULATION OF KINASE ACTIVITY 59 776 2.817e-44 6.242e-42
22 REGULATION OF PROTEIN MODIFICATION PROCESS 77 1710 6.048e-43 1.279e-40
23 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 73 1492 9.472e-43 1.916e-40
24 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 53 616 3.343e-42 6.481e-40
25 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 41 289 3.194e-41 5.944e-39
26 POSITIVE REGULATION OF HYDROLASE ACTIVITY 59 905 1.894e-40 3.39e-38
27 REGULATION OF TRANSFERASE ACTIVITY 59 946 2.334e-39 4.023e-37
28 POSITIVE REGULATION OF MAP KINASE ACTIVITY 35 207 6.963e-38 1.157e-35
29 REGULATION OF GTPASE ACTIVITY 51 673 9.614e-38 1.543e-35
30 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 45 470 1.461e-37 2.267e-35
31 REGULATION OF MAP KINASE ACTIVITY 39 319 1.435e-36 2.154e-34
32 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 30 138 5.497e-36 7.993e-34
33 INOSITOL LIPID MEDIATED SIGNALING 29 124 8.294e-36 1.169e-33
34 REGULATION OF HYDROLASE ACTIVITY 62 1327 3.024e-34 4.139e-32
35 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 38 352 1.562e-33 2.076e-31
36 POSITIVE REGULATION OF LOCOMOTION 40 420 3.676e-33 4.751e-31
37 REGULATION OF CELLULAR COMPONENT MOVEMENT 48 771 1.889e-31 2.376e-29
38 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 30 193 2.62e-31 3.208e-29
39 LOCOMOTION 55 1114 3.468e-31 4.138e-29
40 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 67 1848 1.146e-30 1.333e-28
41 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 33 297 1.71e-29 1.94e-27
42 POSITIVE REGULATION OF CELL PROLIFERATION 47 814 2.639e-29 2.924e-27
43 PHOSPHOLIPID METABOLIC PROCESS 35 364 4.291e-29 4.644e-27
44 RAS PROTEIN SIGNAL TRANSDUCTION 26 143 4.726e-29 4.997e-27
45 GLYCEROLIPID METABOLIC PROCESS 34 356 3.7e-28 3.826e-26
46 ACTIVATION OF PROTEIN KINASE ACTIVITY 31 279 1.041e-27 1.053e-25
47 RESPONSE TO ENDOGENOUS STIMULUS 57 1450 2.784e-27 2.756e-25
48 REGULATION OF CELL PROLIFERATION 56 1496 1.089e-25 1.056e-23
49 TAXIS 35 464 1.741e-25 1.653e-23
50 LIPID PHOSPHORYLATION 21 99 4.1e-25 3.816e-23
51 PEPTIDYL TYROSINE MODIFICATION 25 186 1.589e-24 1.45e-22
52 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 46 1008 2.641e-24 2.363e-22
53 RESPONSE TO GROWTH FACTOR 34 475 5.196e-24 4.561e-22
54 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 28 278 7.324e-24 6.311e-22
55 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 50 1275 1.357e-23 1.148e-21
56 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 29 323 2.857e-23 2.374e-21
57 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 24 184 2.994e-23 2.444e-21
58 RESPONSE TO EXTERNAL STIMULUS 58 1821 3.832e-23 3.074e-21
59 GLYCEROLIPID BIOSYNTHETIC PROCESS 25 211 3.945e-23 3.111e-21
60 RESPONSE TO OXYGEN CONTAINING COMPOUND 51 1381 6.328e-23 4.907e-21
61 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 23 172 1.447e-22 1.104e-20
62 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 55 1672 1.778e-22 1.335e-20
63 RESPONSE TO NITROGEN COMPOUND 41 859 2.772e-22 2.047e-20
64 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 46 1142 4.597e-22 3.342e-20
65 FC RECEPTOR SIGNALING PATHWAY 24 206 4.696e-22 3.361e-20
66 REGULATION OF ERK1 AND ERK2 CASCADE 25 238 8.107e-22 5.715e-20
67 CELL MOTILITY 40 835 8.781e-22 6.009e-20
68 LOCALIZATION OF CELL 40 835 8.781e-22 6.009e-20
69 FC EPSILON RECEPTOR SIGNALING PATHWAY 21 142 1.274e-21 8.592e-20
70 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 43 1021 2.667e-21 1.773e-19
71 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 15 49 6.715e-21 4.401e-19
72 PHOSPHOLIPID BIOSYNTHETIC PROCESS 24 235 1.112e-20 7.186e-19
73 CELLULAR RESPONSE TO PEPTIDE 25 274 2.639e-20 1.682e-18
74 CELLULAR RESPONSE TO NITROGEN COMPOUND 31 505 6.054e-20 3.807e-18
75 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 37 799 1.252e-19 7.77e-18
76 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 47 1395 2.218e-19 1.358e-17
77 REGULATION OF IMMUNE SYSTEM PROCESS 47 1403 2.794e-19 1.688e-17
78 REGULATION OF CELL DEATH 48 1472 3.104e-19 1.852e-17
79 ACTIVATION OF MAPK ACTIVITY 19 137 4.202e-19 2.475e-17
80 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 13 39 8.03e-19 4.63e-17
81 PROTEIN AUTOPHOSPHORYLATION 21 192 8.061e-19 4.63e-17
82 BLOOD VESSEL MORPHOGENESIS 26 364 2.03e-18 1.152e-16
83 RESPONSE TO PEPTIDE 27 404 2.302e-18 1.29e-16
84 REGULATION OF VASCULATURE DEVELOPMENT 22 233 2.785e-18 1.543e-16
85 ORGANOPHOSPHATE METABOLIC PROCESS 37 885 3.684e-18 2.017e-16
86 RESPONSE TO HORMONE 37 893 4.947e-18 2.677e-16
87 LIPID MODIFICATION 21 210 5.242e-18 2.804e-16
88 REGULATION OF ENDOTHELIAL CELL MIGRATION 17 114 9.426e-18 4.984e-16
89 VASCULATURE DEVELOPMENT 28 469 9.744e-18 5.094e-16
90 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 14 62 1.692e-17 8.746e-16
91 REGULATION OF PHOSPHOLIPASE ACTIVITY 14 64 2.749e-17 1.406e-15
92 CARDIOVASCULAR SYSTEM DEVELOPMENT 34 788 4.221e-17 2.112e-15
93 CIRCULATORY SYSTEM DEVELOPMENT 34 788 4.221e-17 2.112e-15
94 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 13 53 7.617e-17 3.77e-15
95 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 40 8.014e-17 3.925e-15
96 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 35 867 1.045e-16 5.065e-15
97 CELL DEVELOPMENT 44 1426 1.168e-16 5.601e-15
98 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 20 213 1.18e-16 5.605e-15
99 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 55 1.297e-16 6.097e-15
100 CELL PROLIFERATION 31 672 2.036e-16 9.472e-15
101 REGULATION OF EPITHELIAL CELL MIGRATION 18 166 3.341e-16 1.539e-14
102 ANGIOGENESIS 22 293 3.702e-16 1.689e-14
103 CELLULAR LIPID METABOLIC PROCESS 35 913 5.079e-16 2.295e-14
104 REGULATION OF IMMUNE RESPONSE 34 858 5.407e-16 2.419e-14
105 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 13 61 5.652e-16 2.505e-14
106 REGULATION OF CELL DIFFERENTIATION 44 1492 6.142e-16 2.696e-14
107 CELLULAR RESPONSE TO HORMONE STIMULUS 28 552 6.47e-16 2.813e-14
108 REGULATION OF LIPID KINASE ACTIVITY 12 48 9.503e-16 4.094e-14
109 REGULATION OF TRANSPORT 48 1804 1.066e-15 4.55e-14
110 REGULATION OF LIPASE ACTIVITY 14 83 1.348e-15 5.704e-14
111 REGULATION OF CHEMOTAXIS 18 180 1.421e-15 5.956e-14
112 POSITIVE REGULATION OF LIPASE ACTIVITY 13 66 1.706e-15 7.086e-14
113 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 38 1152 2.882e-15 1.187e-13
114 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 16 133 3.026e-15 1.235e-13
115 NEURON PROJECTION DEVELOPMENT 27 545 4.061e-15 1.643e-13
116 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 34 926 5.128e-15 2.057e-13
117 LEUKOCYTE MIGRATION 20 259 5.25e-15 2.088e-13
118 NEGATIVE REGULATION OF CELL DEATH 33 872 5.895e-15 2.324e-13
119 POSITIVE REGULATION OF CELL DIFFERENTIATION 32 823 7.728e-15 3.022e-13
120 IMMUNE SYSTEM PROCESS 49 1984 9.004e-15 3.462e-13
121 RESPONSE TO WOUNDING 27 563 8.956e-15 3.462e-13
122 WOUND HEALING 25 470 9.461e-15 3.608e-13
123 NEUROGENESIS 41 1402 1.068e-14 4.041e-13
124 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 15 120 1.292e-14 4.809e-13
125 POSITIVE REGULATION OF CHEMOTAXIS 15 120 1.292e-14 4.809e-13
126 PEPTIDYL AMINO ACID MODIFICATION 32 841 1.408e-14 5.201e-13
127 REGULATION OF CELL ADHESION 28 629 1.727e-14 6.327e-13
128 ERBB SIGNALING PATHWAY 13 79 2.028e-14 7.374e-13
129 LIPID BIOSYNTHETIC PROCESS 26 539 2.601e-14 9.383e-13
130 REGULATION OF LIPID METABOLIC PROCESS 20 282 2.66e-14 9.52e-13
131 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 16 154 3.163e-14 1.124e-12
132 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 24 450 3.232e-14 1.139e-12
133 POSITIVE REGULATION OF DNA METABOLIC PROCESS 17 185 3.737e-14 1.308e-12
134 REGULATION OF RESPONSE TO STRESS 41 1468 4.999e-14 1.736e-12
135 POSITIVE REGULATION OF CELL DIVISION 15 132 5.456e-14 1.881e-12
136 POSITIVE REGULATION OF DNA REPLICATION 13 86 6.401e-14 2.19e-12
137 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 20 296 6.647e-14 2.258e-12
138 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 12 67 7.256e-14 2.447e-12
139 LIPID METABOLIC PROCESS 36 1158 1.09e-13 3.65e-12
140 NEURON DEVELOPMENT 28 687 1.521e-13 5.019e-12
141 TISSUE DEVELOPMENT 41 1518 1.519e-13 5.019e-12
142 REGULATION OF PHOSPHOLIPASE C ACTIVITY 10 39 1.916e-13 6.277e-12
143 CELLULAR RESPONSE TO INSULIN STIMULUS 15 146 2.461e-13 8.007e-12
144 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 44 1805 5.328e-13 1.722e-11
145 INSULIN RECEPTOR SIGNALING PATHWAY 12 80 6.716e-13 2.141e-11
146 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 14 128 6.682e-13 2.141e-11
147 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 13 103 7.072e-13 2.239e-11
148 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 19 303 1.109e-12 3.486e-11
149 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 15 162 1.142e-12 3.567e-11
150 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 9 32 1.263e-12 3.918e-11
151 EPHRIN RECEPTOR SIGNALING PATHWAY 12 85 1.421e-12 4.379e-11
152 NEURON DIFFERENTIATION 30 874 1.509e-12 4.619e-11
153 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 8 22 2.176e-12 6.619e-11
154 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 34 2.332e-12 7.046e-11
155 TUBE DEVELOPMENT 24 552 2.632e-12 7.9e-11
156 EMBRYO DEVELOPMENT 30 894 2.671e-12 7.968e-11
157 RESPONSE TO INSULIN 16 205 2.746e-12 8.138e-11
158 RESPONSE TO ABIOTIC STIMULUS 32 1024 2.917e-12 8.591e-11
159 REGULATION OF CELL PROJECTION ORGANIZATION 24 558 3.307e-12 9.645e-11
160 PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 8 23 3.317e-12 9.645e-11
161 CELL PROJECTION ORGANIZATION 30 902 3.342e-12 9.66e-11
162 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 10 51 3.57e-12 1.025e-10
163 REGULATION OF NEURON DEATH 17 252 5.785e-12 1.651e-10
164 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 74 7.016e-12 1.991e-10
165 CELLULAR RESPONSE TO GLUCAGON STIMULUS 9 38 7.068e-12 1.993e-10
166 ERBB2 SIGNALING PATHWAY 9 39 9.131e-12 2.56e-10
167 PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 8 26 1.037e-11 2.89e-10
168 EPITHELIUM DEVELOPMENT 30 945 1.07e-11 2.963e-10
169 PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 7 16 1.14e-11 3.138e-10
170 CELLULAR COMPONENT MORPHOGENESIS 29 900 1.752e-11 4.796e-10
171 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 9 42 1.886e-11 5.101e-10
172 NEURON PROJECTION MORPHOGENESIS 20 402 1.875e-11 5.101e-10
173 PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 7 17 1.925e-11 5.131e-10
174 ORGAN MORPHOGENESIS 28 841 1.93e-11 5.131e-10
175 PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 7 17 1.925e-11 5.131e-10
176 REGULATION OF CELL DIVISION 17 272 1.949e-11 5.153e-10
177 REGULATION OF ORGANELLE ORGANIZATION 33 1178 2.361e-11 6.207e-10
178 RESPONSE TO ORGANIC CYCLIC COMPOUND 29 917 2.747e-11 7.18e-10
179 POSITIVE REGULATION OF IMMUNE RESPONSE 23 563 2.763e-11 7.183e-10
180 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 84 2.927e-11 7.567e-10
181 REGULATION OF CELL SUBSTRATE ADHESION 14 173 4.161e-11 1.07e-09
182 CELL DEATH 30 1001 4.424e-11 1.131e-09
183 POSITIVE REGULATION OF CELL DEVELOPMENT 21 472 4.556e-11 1.159e-09
184 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 26 750 4.649e-11 1.176e-09
185 PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 8 31 5.076e-11 1.277e-09
186 ACTIVATION OF IMMUNE RESPONSE 20 427 5.523e-11 1.382e-09
187 REGULATION OF CELL MATRIX ADHESION 11 90 6.314e-11 1.571e-09
188 RESPONSE TO GLUCAGON 9 48 6.83e-11 1.69e-09
189 REGULATION OF DNA METABOLIC PROCESS 18 340 7.49e-11 1.844e-09
190 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 29 957 7.595e-11 1.85e-09
191 CELL CELL SIGNALING 26 767 7.584e-11 1.85e-09
192 PHOSPHATIDIC ACID METABOLIC PROCESS 8 33 8.823e-11 2.138e-09
193 MORPHOGENESIS OF AN EPITHELIUM 19 400 1.369e-10 3.301e-09
194 REGULATION OF NEURON APOPTOTIC PROCESS 14 192 1.677e-10 4.023e-09
195 POSITIVE CHEMOTAXIS 8 36 1.887e-10 4.504e-09
196 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 513 2.109e-10 5.007e-09
197 REGULATION OF DNA REPLICATION 13 161 2.186e-10 5.164e-09
198 POSITIVE REGULATION OF TRANSPORT 28 936 2.284e-10 5.367e-09
199 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 13 162 2.362e-10 5.523e-09
200 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 8 37 2.393e-10 5.567e-09
201 REGULATION OF EPITHELIAL CELL PROLIFERATION 16 285 3.845e-10 8.902e-09
202 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 6 14 4.241e-10 9.77e-09
203 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 7 25 4.529e-10 1.038e-08
204 NEGATIVE REGULATION OF NEURON DEATH 13 171 4.629e-10 1.056e-08
205 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 8 40 4.678e-10 1.062e-08
206 REGULATION OF CELL DEVELOPMENT 26 836 4.852e-10 1.096e-08
207 REGULATION OF CELL MORPHOGENESIS 21 552 7.95e-10 1.787e-08
208 REGULATION OF CELLULAR LOCALIZATION 32 1277 8.408e-10 1.881e-08
209 REGULATION OF HOMEOSTATIC PROCESS 19 447 8.834e-10 1.967e-08
210 T CELL RECEPTOR SIGNALING PATHWAY 12 146 9.051e-10 2.005e-08
211 PHOSPHATIDYLCHOLINE METABOLIC PROCESS 9 64 1.015e-09 2.227e-08
212 RESPONSE TO FIBROBLAST GROWTH FACTOR 11 116 1.013e-09 2.227e-08
213 PHOSPHATIDYLSERINE METABOLIC PROCESS 7 28 1.095e-09 2.392e-08
214 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 6 17 1.716e-09 3.714e-08
215 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 17 1.716e-09 3.714e-08
216 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 14 232 2.009e-09 4.327e-08
217 POSITIVE REGULATION OF AXONOGENESIS 9 69 2.023e-09 4.338e-08
218 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 17 368 2.086e-09 4.453e-08
219 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 13 195 2.327e-09 4.945e-08
220 TUBE MORPHOGENESIS 16 323 2.362e-09 4.996e-08
221 SECRETION 21 588 2.455e-09 5.169e-08
222 POSITIVE REGULATION OF CELL ADHESION 17 376 2.883e-09 6.043e-08
223 REGULATION OF DEVELOPMENTAL GROWTH 15 289 4.089e-09 8.533e-08
224 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 18 437 4.15e-09 8.622e-08
225 MORPHOGENESIS OF A BRANCHING STRUCTURE 12 167 4.222e-09 8.731e-08
226 NEURON PROJECTION GUIDANCE 13 205 4.272e-09 8.796e-08
227 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 16 337 4.334e-09 8.884e-08
228 REGULATION OF AXONOGENESIS 12 168 4.518e-09 9.221e-08
229 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 8 53 4.972e-09 1.01e-07
230 REGULATION OF NEURON DIFFERENTIATION 20 554 5.09e-09 1.03e-07
231 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 11 135 5.114e-09 1.03e-07
232 COGNITION 14 251 5.533e-09 1.11e-07
233 ALDITOL PHOSPHATE METABOLIC PROCESS 7 35 5.956e-09 1.189e-07
234 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 10 106 6.297e-09 1.252e-07
235 RESPONSE TO LIPID 25 888 8.177e-09 1.619e-07
236 REGULATION OF FIBROBLAST PROLIFERATION 9 81 8.639e-09 1.703e-07
237 PLATELET ACTIVATION 11 142 8.716e-09 1.711e-07
238 CELL PART MORPHOGENESIS 21 633 8.966e-09 1.748e-07
239 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 20 573 8.98e-09 1.748e-07
240 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 5 11 9.243e-09 1.792e-07
241 REGULATION OF NEURON PROJECTION DEVELOPMENT 17 408 9.737e-09 1.88e-07
242 REGULATION OF VESICLE MEDIATED TRANSPORT 18 462 9.852e-09 1.894e-07
243 REGULATION OF CELLULAR COMPONENT BIOGENESIS 23 767 1.091e-08 2.09e-07
244 HEMOSTASIS 15 311 1.099e-08 2.096e-07
245 HEART DEVELOPMENT 18 466 1.125e-08 2.137e-07
246 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 8 59 1.198e-08 2.266e-07
247 ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 9 85 1.33e-08 2.505e-07
248 POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 6 23 1.35e-08 2.532e-07
249 REGULATION OF GLUCOSE IMPORT 8 60 1.374e-08 2.568e-07
250 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 31 1360 1.521e-08 2.831e-07
251 TISSUE MORPHOGENESIS 19 533 1.558e-08 2.889e-07
252 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 5 12 1.575e-08 2.908e-07
253 REGULATION OF POSITIVE CHEMOTAXIS 6 24 1.788e-08 3.289e-07
254 POSITIVE REGULATION OF GLUCOSE TRANSPORT 7 42 2.288e-08 4.192e-07
255 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 25 2.339e-08 4.268e-07
256 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 12 197 2.702e-08 4.911e-07
257 CELL CHEMOTAXIS 11 162 3.442e-08 6.233e-07
258 FC GAMMA RECEPTOR SIGNALING PATHWAY 9 95 3.564e-08 6.427e-07
259 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 68 3.777e-08 6.785e-07
260 REGULATION OF BODY FLUID LEVELS 18 506 3.961e-08 7.062e-07
261 LIPID CATABOLIC PROCESS 13 247 3.954e-08 7.062e-07
262 GLAND DEVELOPMENT 16 395 4.031e-08 7.159e-07
263 ALCOHOL METABOLIC PROCESS 15 348 4.877e-08 8.596e-07
264 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 10 131 4.872e-08 8.596e-07
265 MODULATION OF SYNAPTIC TRANSMISSION 14 301 5.465e-08 9.596e-07
266 REGULATION OF GLUCOSE TRANSPORT 9 100 5.592e-08 9.781e-07
267 EMBRYONIC ORGAN DEVELOPMENT 16 406 5.887e-08 1.026e-06
268 IMMUNE SYSTEM DEVELOPMENT 19 582 6.271e-08 1.089e-06
269 POSITIVE REGULATION OF NEURON DIFFERENTIATION 14 306 6.704e-08 1.16e-06
270 GROWTH 16 410 6.736e-08 1.161e-06
271 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 103 7.24e-08 1.243e-06
272 RESPONSE TO RADIATION 16 413 7.444e-08 1.273e-06
273 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 6 30 7.606e-08 1.296e-06
274 EXOCYTOSIS 14 310 7.871e-08 1.337e-06
275 RESPONSE TO OXYGEN LEVELS 14 311 8.19e-08 1.386e-06
276 REGULATION OF ACTIN FILAMENT BASED PROCESS 14 312 8.521e-08 1.437e-06
277 REGULATION OF SYNAPTIC PLASTICITY 10 140 9.157e-08 1.538e-06
278 PLATELET DEGRANULATION 9 107 1.009e-07 1.688e-06
279 VESICLE MEDIATED TRANSPORT 28 1239 1.032e-07 1.721e-06
280 POSITIVE REGULATION OF GENE EXPRESSION 34 1733 1.061e-07 1.763e-06
281 REGULATED EXOCYTOSIS 12 224 1.11e-07 1.838e-06
282 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 6 32 1.147e-07 1.892e-06
283 REGULATION OF CELL ACTIVATION 17 484 1.163e-07 1.913e-06
284 SECRETION BY CELL 17 486 1.234e-07 2.021e-06
285 HOMEOSTATIC PROCESS 29 1337 1.404e-07 2.292e-06
286 REGULATION OF CELL CELL ADHESION 15 380 1.531e-07 2.491e-06
287 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 12 232 1.625e-07 2.634e-06
288 RESPONSE TO LIGHT STIMULUS 13 280 1.704e-07 2.752e-06
289 SINGLE ORGANISM BEHAVIOR 15 384 1.752e-07 2.821e-06
290 POSITIVE REGULATION OF CELL CYCLE 14 332 1.825e-07 2.929e-06
291 REGULATION OF DEFENSE RESPONSE 21 759 1.96e-07 3.133e-06
292 CELL ACTIVATION 18 568 2.224e-07 3.545e-06
293 REGULATION OF GROWTH 19 633 2.303e-07 3.658e-06
294 ACTIN FILAMENT BASED PROCESS 16 450 2.385e-07 3.775e-06
295 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 10 156 2.529e-07 3.989e-06
296 EMBRYONIC HEMOPOIESIS 5 20 2.939e-07 4.605e-06
297 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 7 60 2.931e-07 4.605e-06
298 CALCIUM MEDIATED SIGNALING 8 90 3.453e-07 5.392e-06
299 RHYTHMIC PROCESS 13 298 3.478e-07 5.412e-06
300 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 15 406 3.572e-07 5.54e-06
301 REPRODUCTIVE SYSTEM DEVELOPMENT 15 408 3.802e-07 5.877e-06
302 EPIDERMIS DEVELOPMENT 12 253 4.125e-07 6.356e-06
303 REGULATION OF CALCIUM ION TRANSPORT 11 209 4.568e-07 7.014e-06
304 POSITIVE REGULATION OF CELL MATRIX ADHESION 6 40 4.627e-07 7.081e-06
305 CENTRAL NERVOUS SYSTEM DEVELOPMENT 22 872 4.704e-07 7.177e-06
306 CHEMICAL HOMEOSTASIS 22 874 4.889e-07 7.411e-06
307 REGULATION OF HOMOTYPIC CELL CELL ADHESION 13 307 4.876e-07 7.411e-06
308 SINGLE ORGANISM BIOSYNTHETIC PROCESS 28 1340 5.11e-07 7.72e-06
309 REGULATION OF PROTEIN LOCALIZATION 23 950 5.142e-07 7.743e-06
310 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 18 602 5.197e-07 7.8e-06
311 AMMONIUM ION METABOLIC PROCESS 10 169 5.311e-07 7.946e-06
312 POSITIVE REGULATION OF DEFENSE RESPONSE 14 364 5.545e-07 8.27e-06
313 AMINE METABOLIC PROCESS 9 131 5.723e-07 8.508e-06
314 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 16 482 5.96e-07 8.831e-06
315 NEUROTROPHIN SIGNALING PATHWAY 5 23 6.266e-07 9.257e-06
316 MEMORY 8 98 6.67e-07 9.79e-06
317 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 98 6.67e-07 9.79e-06
318 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 6 43 7.215e-07 1.056e-05
319 RESPONSE TO ACID CHEMICAL 13 319 7.515e-07 1.096e-05
320 REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 5 24 7.869e-07 1.144e-05
321 REGULATION OF INTRACELLULAR TRANSPORT 18 621 8.134e-07 1.179e-05
322 REGULATION OF CELLULAR RESPONSE TO STRESS 19 691 8.669e-07 1.253e-05
323 MULTICELLULAR ORGANISMAL HOMEOSTASIS 12 272 8.891e-07 1.281e-05
324 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 23 983 9.271e-07 1.331e-05
325 CELLULAR RESPONSE TO STRESS 30 1565 1.142e-06 1.636e-05
326 HEAD DEVELOPMENT 19 709 1.27e-06 1.813e-05
327 BEHAVIOR 16 516 1.456e-06 2.072e-05
328 REGULATION OF NEURONAL SYNAPTIC PLASTICITY 6 49 1.596e-06 2.257e-05
329 PEPTIDYL SERINE MODIFICATION 9 148 1.595e-06 2.257e-05
330 POSITIVE REGULATION OF GROWTH 11 238 1.642e-06 2.316e-05
331 APOPTOTIC SIGNALING PATHWAY 12 289 1.678e-06 2.358e-05
332 REGULATION OF CELL CYCLE 22 949 1.915e-06 2.683e-05
333 REGULATION OF ORGAN MORPHOGENESIS 11 242 1.931e-06 2.699e-05
334 OVULATION CYCLE 8 113 1.976e-06 2.752e-05
335 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 9 152 1.99e-06 2.764e-05
336 POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 6 51 2.03e-06 2.811e-05
337 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 11 246 2.264e-06 3.126e-05
338 REGULATION OF RESPONSE TO WOUNDING 14 413 2.459e-06 3.385e-05
339 JNK CASCADE 7 82 2.52e-06 3.458e-05
340 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 6 53 2.557e-06 3.489e-05
341 POSITIVE REGULATION OF CELL DEATH 17 605 2.556e-06 3.489e-05
342 REGULATION OF ION HOMEOSTASIS 10 201 2.571e-06 3.497e-05
343 REGULATION OF INNATE IMMUNE RESPONSE 13 357 2.623e-06 3.558e-05
344 ARACHIDONIC ACID SECRETION 4 14 2.721e-06 3.669e-05
345 ARACHIDONATE TRANSPORT 4 14 2.721e-06 3.669e-05
346 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 8 118 2.738e-06 3.682e-05
347 ACTIVATION OF INNATE IMMUNE RESPONSE 10 204 2.935e-06 3.936e-05
348 REGULATION OF CYTOPLASMIC TRANSPORT 15 481 2.949e-06 3.943e-05
349 HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 5 31 3.017e-06 4.022e-05
350 SECOND MESSENGER MEDIATED SIGNALING 9 160 3.041e-06 4.042e-05
351 RESPONSE TO ALCOHOL 13 362 3.055e-06 4.049e-05
352 REGULATION OF PROTEIN KINASE B SIGNALING 8 121 3.305e-06 4.369e-05
353 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 16 554 3.63e-06 4.785e-05
354 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 4 15 3.689e-06 4.835e-05
355 NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 4 15 3.689e-06 4.835e-05
356 POSITIVE REGULATION OF MITOTIC CELL CYCLE 8 123 3.736e-06 4.884e-05
357 RESPONSE TO MECHANICAL STIMULUS 10 210 3.802e-06 4.955e-05
358 CYTOSKELETON ORGANIZATION 20 838 3.822e-06 4.968e-05
359 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 13 370 3.877e-06 5.025e-05
360 SENSORY ORGAN DEVELOPMENT 15 493 3.978e-06 5.142e-05
361 OVULATION CYCLE PROCESS 7 88 4.055e-06 5.183e-05
362 REGULATION OF STEM CELL PROLIFERATION 7 88 4.055e-06 5.183e-05
363 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 88 4.055e-06 5.183e-05
364 REGULATION OF CATION CHANNEL ACTIVITY 7 88 4.055e-06 5.183e-05
365 EPITHELIAL CELL PROLIFERATION 7 89 4.374e-06 5.576e-05
366 VASCULOGENESIS 6 59 4.838e-06 6.151e-05
367 REGULATION OF CYTOSKELETON ORGANIZATION 15 502 4.949e-06 6.275e-05
368 REGULATION OF LIPID BIOSYNTHETIC PROCESS 8 128 5.028e-06 6.358e-05
369 TISSUE HOMEOSTASIS 9 171 5.242e-06 6.61e-05
370 REGULATION OF SYSTEM PROCESS 15 507 5.576e-06 7.012e-05
371 REGULATION OF METAL ION TRANSPORT 12 325 5.613e-06 7.04e-05
372 SYSTEM PROCESS 31 1785 5.735e-06 7.174e-05
373 POSITIVE REGULATION OF STEM CELL PROLIFERATION 6 61 5.89e-06 7.348e-05
374 LEARNING 8 131 5.971e-06 7.429e-05
375 CELLULAR RESPONSE TO ACID CHEMICAL 9 175 6.327e-06 7.85e-05
376 POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 4 17 6.358e-06 7.868e-05
377 POSITIVE REGULATION OF NUCLEAR DIVISION 6 62 6.482e-06 8e-05
378 MYELOID LEUKOCYTE DIFFERENTIATION 7 96 7.247e-06 8.92e-05
379 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 19 801 7.447e-06 9.142e-05
380 GLAND MORPHOGENESIS 7 97 7.762e-06 9.505e-05
381 MYELOID LEUKOCYTE MIGRATION 7 99 8.885e-06 0.0001079
382 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 7 99 8.885e-06 0.0001079
383 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 7 99 8.885e-06 0.0001079
384 ACID SECRETION 6 66 9.35e-06 0.0001133
385 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 7 100 9.495e-06 0.0001148
386 KIDNEY VASCULATURE DEVELOPMENT 4 19 1.024e-05 0.0001231
387 RENAL SYSTEM VASCULATURE DEVELOPMENT 4 19 1.024e-05 0.0001231
388 POSITIVE REGULATION OF ION TRANSPORT 10 236 1.063e-05 0.0001275
389 REGULATION OF CELL JUNCTION ASSEMBLY 6 68 1.113e-05 0.0001331
390 EMBRYONIC MORPHOGENESIS 15 539 1.155e-05 0.0001379
391 MYELOID CELL DIFFERENTIATION 9 189 1.177e-05 0.0001401
392 PHAGOCYTOSIS 9 190 1.228e-05 0.0001458
393 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 5 41 1.254e-05 0.0001484
394 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 4 20 1.272e-05 0.0001495
395 ICOSANOID TRANSPORT 4 20 1.272e-05 0.0001495
396 FATTY ACID DERIVATIVE TRANSPORT 4 20 1.272e-05 0.0001495
397 CEREBRAL CORTEX DEVELOPMENT 7 105 1.309e-05 0.0001534
398 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 6 70 1.317e-05 0.000154
399 RESPONSE TO ESTRADIOL 8 146 1.325e-05 0.0001545
400 POSITIVE REGULATION OF CELL CELL ADHESION 10 243 1.371e-05 0.0001594
401 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 7 106 1.393e-05 0.0001617
402 FOREBRAIN DEVELOPMENT 12 357 1.442e-05 0.0001668
403 UROGENITAL SYSTEM DEVELOPMENT 11 299 1.445e-05 0.0001668
404 REGULATION OF CELLULAR PROTEIN LOCALIZATION 15 552 1.529e-05 0.0001761
405 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 21 1.562e-05 0.0001795
406 RESPIRATORY SYSTEM DEVELOPMENT 9 197 1.639e-05 0.0001879
407 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 7 109 1.672e-05 0.0001907
408 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 7 109 1.672e-05 0.0001907
409 ASSOCIATIVE LEARNING 6 73 1.679e-05 0.000191
410 REGULATION OF SECRETION 17 699 1.698e-05 0.0001927
411 REGULATION OF TRANSPORTER ACTIVITY 9 198 1.706e-05 0.0001932
412 OSSIFICATION 10 251 1.813e-05 0.0002048
413 SOMATIC STEM CELL DIVISION 4 22 1.899e-05 0.0002139
414 ACTIVATION OF GTPASE ACTIVITY 6 75 1.962e-05 0.00022
415 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 6 75 1.962e-05 0.00022
416 SPROUTING ANGIOGENESIS 5 45 1.996e-05 0.0002227
417 EXOCRINE SYSTEM DEVELOPMENT 5 45 1.996e-05 0.0002227
418 RESPONSE TO STEROID HORMONE 14 497 2.007e-05 0.0002234
419 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 8 156 2.142e-05 0.0002379
420 NEGATIVE REGULATION OF CELL COMMUNICATION 23 1192 2.221e-05 0.0002461
421 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 13 437 2.285e-05 0.0002525
422 NEPHRON DEVELOPMENT 7 115 2.37e-05 0.0002613
423 LYMPHOCYTE COSTIMULATION 6 78 2.457e-05 0.0002697
424 REGULATION OF JNK CASCADE 8 159 2.458e-05 0.0002697
425 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 7 116 2.507e-05 0.0002738
426 FEMALE SEX DIFFERENTIATION 7 116 2.507e-05 0.0002738
427 REGULATION OF RECEPTOR ACTIVITY 7 117 2.65e-05 0.0002881
428 LEUKOCYTE CHEMOTAXIS 7 117 2.65e-05 0.0002881
429 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 24 2.726e-05 0.0002957
430 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 6 80 2.84e-05 0.0003074
431 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 14 514 2.905e-05 0.0003136
432 GLOMERULUS DEVELOPMENT 5 49 3.042e-05 0.0003269
433 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 5 49 3.042e-05 0.0003269
434 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 6 81 3.049e-05 0.0003269
435 REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 4 25 3.227e-05 0.0003452
436 REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 50 3.36e-05 0.0003578
437 VISUAL BEHAVIOR 5 50 3.36e-05 0.0003578
438 REGULATION OF ION TRANSPORT 15 592 3.437e-05 0.0003651
439 SKELETAL SYSTEM DEVELOPMENT 13 455 3.471e-05 0.0003679
440 EMBRYONIC PLACENTA DEVELOPMENT 6 83 3.503e-05 0.0003705
441 RESPONSE TO ESTROGEN 9 218 3.643e-05 0.0003843
442 TISSUE MIGRATION 6 84 3.75e-05 0.0003948
443 DEVELOPMENTAL GROWTH 11 333 3.888e-05 0.0004084
444 GLUCOSE HOMEOSTASIS 8 170 3.966e-05 0.0004147
445 CARBOHYDRATE HOMEOSTASIS 8 170 3.966e-05 0.0004147
446 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 6 86 4.285e-05 0.0004471
447 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 27 4.426e-05 0.0004597
448 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 4.426e-05 0.0004597
449 MAMMARY GLAND EPITHELIUM DEVELOPMENT 5 53 4.47e-05 0.0004612
450 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 5 53 4.47e-05 0.0004612
451 CELLULAR RESPONSE TO AMINO ACID STIMULUS 5 53 4.47e-05 0.0004612
452 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 6 87 4.575e-05 0.000471
453 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 10 282 4.881e-05 0.0005002
454 HOMEOSTASIS OF NUMBER OF CELLS 8 175 4.872e-05 0.0005002
455 POSITIVE REGULATION OF CALCIUM ION IMPORT 5 54 4.897e-05 0.0005008
456 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 4 28 5.134e-05 0.0005227
457 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 5.134e-05 0.0005227
458 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 6 89 5.201e-05 0.0005273
459 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 20 1004 5.196e-05 0.0005273
460 REGULATION OF KIDNEY DEVELOPMENT 5 55 5.355e-05 0.0005405
461 ACTIN CYTOSKELETON REORGANIZATION 5 55 5.355e-05 0.0005405
462 REGULATION OF OXIDOREDUCTASE ACTIVITY 6 90 5.539e-05 0.0005566
463 MIDBRAIN DEVELOPMENT 6 90 5.539e-05 0.0005566
464 INOSITOL PHOSPHATE METABOLIC PROCESS 5 56 5.845e-05 0.0005862
465 STEM CELL DIVISION 4 29 5.921e-05 0.0005925
466 CHEMICAL HOMEOSTASIS WITHIN A TISSUE 3 11 6.273e-05 0.0006263
467 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 7 135 6.622e-05 0.0006598
468 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 4 30 6.793e-05 0.0006732
469 OSTEOCLAST DIFFERENTIATION 4 30 6.793e-05 0.0006732
470 IMMUNE EFFECTOR PROCESS 13 486 6.8e-05 0.0006732
471 REGULATION OF DNA BIOSYNTHETIC PROCESS 6 94 7.07e-05 0.0006985
472 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 5 59 7.526e-05 0.0007419
473 PLACENTA DEVELOPMENT 7 138 7.609e-05 0.0007485
474 REGULATION OF PLATELET ACTIVATION 4 31 7.755e-05 0.0007612
475 REGULATION OF TRANSMEMBRANE TRANSPORT 12 426 8.024e-05 0.000786
476 REGULATION OF MONOOXYGENASE ACTIVITY 5 60 8.162e-05 0.0007961
477 REPRODUCTION 23 1297 8.161e-05 0.0007961
478 REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 3 12 8.318e-05 0.0008097
479 STEM CELL DIFFERENTIATION 8 190 8.684e-05 0.0008436
480 SALIVARY GLAND DEVELOPMENT 4 32 8.812e-05 0.0008511
481 OVARIAN FOLLICLE DEVELOPMENT 5 61 8.838e-05 0.0008511
482 POSITIVE REGULATION OF CYCLASE ACTIVITY 5 61 8.838e-05 0.0008511
483 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 11 365 8.853e-05 0.0008511
484 CELLULAR CHEMICAL HOMEOSTASIS 14 570 8.831e-05 0.0008511
485 MUSCLE STRUCTURE DEVELOPMENT 12 432 9.158e-05 0.0008786
486 REGULATION OF AUTOPHAGY 9 249 0.0001015 0.0009713
487 NEURONAL STEM CELL DIVISION 3 13 0.0001076 0.001021
488 INDUCTION OF POSITIVE CHEMOTAXIS 3 13 0.0001076 0.001021
489 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 0.0001076 0.001021
490 NEUROBLAST DIVISION 3 13 0.0001076 0.001021
491 ENDOCYTOSIS 13 509 0.0001081 0.001024
492 IN UTERO EMBRYONIC DEVELOPMENT 10 311 0.00011 0.001038
493 POSITIVE REGULATION OF CELL ACTIVATION 10 311 0.00011 0.001038
494 NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 5 64 0.0001113 0.001048
495 FOREBRAIN NEURON DEVELOPMENT 4 34 0.0001123 0.00105
496 NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY 4 34 0.0001123 0.00105
497 REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 34 0.0001123 0.00105
498 PROTEIN KINASE B SIGNALING 4 34 0.0001123 0.00105
499 REGULATION OF CALCIUM ION IMPORT 6 103 0.0001176 0.001096
500 REGULATION OF ENDOCYTOSIS 8 199 0.0001198 0.001114
501 REGULATION OF LEUKOCYTE MIGRATION 7 149 0.0001231 0.001143
502 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 6 104 0.000124 0.00115
503 REGULATION OF GLYCOGEN METABOLIC PROCESS 4 35 0.0001261 0.001167
504 FOREBRAIN GENERATION OF NEURONS 5 66 0.0001289 0.001188
505 REGULATION OF MULTICELLULAR ORGANISM GROWTH 5 66 0.0001289 0.001188
506 REGULATION OF RESPIRATORY BURST 3 14 0.0001361 0.001242
507 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 3 14 0.0001361 0.001242
508 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 14 0.0001361 0.001242
509 REGULATION OF GLOMERULUS DEVELOPMENT 3 14 0.0001361 0.001242
510 REGULATION OF PROTEIN KINASE C SIGNALING 3 14 0.0001361 0.001242
511 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 8 203 0.0001374 0.001251
512 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 4 36 0.0001411 0.001282
513 REGULATION OF SEQUESTERING OF CALCIUM ION 6 107 0.0001451 0.001311
514 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 7 153 0.0001451 0.001311
515 PALLIUM DEVELOPMENT 7 153 0.0001451 0.001311
516 INFLAMMATORY RESPONSE 12 454 0.0001458 0.001315
517 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 5 68 0.0001486 0.001337
518 AMEBOIDAL TYPE CELL MIGRATION 7 154 0.0001511 0.001357
519 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 6 108 0.0001527 0.001369
520 CELLULAR RESPONSE TO ABIOTIC STIMULUS 9 263 0.0001533 0.001372
521 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 37 0.0001573 0.001402
522 REGULATION OF CELL PROJECTION ASSEMBLY 7 155 0.0001573 0.001402
523 EYE DEVELOPMENT 10 326 0.0001614 0.001436
524 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 8 208 0.0001624 0.001442
525 BONE DEVELOPMENT 7 156 0.0001637 0.00145
526 SEX DIFFERENTIATION 9 266 0.0001669 0.001476
527 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 3 15 0.0001693 0.001492
528 REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 3 15 0.0001693 0.001492
529 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 5 70 0.0001705 0.001499
530 SKIN DEVELOPMENT 8 211 0.0001791 0.001572
531 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 12 465 0.0001819 0.001594
532 SKIN EPIDERMIS DEVELOPMENT 5 71 0.0001823 0.001594
533 RESPONSE TO AMINO ACID 6 112 0.0001863 0.001626
534 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 4 39 0.0001936 0.001671
535 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 4 39 0.0001936 0.001671
536 ASTROCYTE DIFFERENTIATION 4 39 0.0001936 0.001671
537 EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 39 0.0001936 0.001671
538 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 4 39 0.0001936 0.001671
539 REGULATION OF MITOTIC CELL CYCLE 12 468 0.000193 0.001671
540 POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 3 16 0.0002072 0.001767
541 CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE 3 16 0.0002072 0.001767
542 POSITIVE REGULATION OF STAT CASCADE 5 73 0.0002078 0.001767
543 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 3 16 0.0002072 0.001767
544 REGULATION OF EMBRYONIC DEVELOPMENT 6 114 0.0002052 0.001767
545 POSITIVE REGULATION OF JAK STAT CASCADE 5 73 0.0002078 0.001767
546 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 16 0.0002072 0.001767
547 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 3 16 0.0002072 0.001767
548 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 9 274 0.0002082 0.001767
549 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 8 216 0.00021 0.00178
550 MAMMARY GLAND MORPHOGENESIS 4 40 0.0002139 0.00181
551 MAMMARY GLAND DEVELOPMENT 6 117 0.0002363 0.001995
552 RESPONSE TO INORGANIC SUBSTANCE 12 479 0.0002388 0.002013
553 DIVALENT INORGANIC CATION HOMEOSTASIS 10 343 0.000243 0.002045
554 MESODERM DEVELOPMENT 6 118 0.0002475 0.002078
555 NEGATIVE REGULATION OF PLATELET ACTIVATION 3 17 0.0002502 0.00209
556 NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 3 17 0.0002502 0.00209
557 NEGATIVE REGULATION OF ANOIKIS 3 17 0.0002502 0.00209
558 SINGLE ORGANISM CATABOLIC PROCESS 18 957 0.0002569 0.002142
559 LONG CHAIN FATTY ACID TRANSPORT 4 42 0.000259 0.002156
560 REGULATION OF BINDING 9 283 0.0002644 0.002197
561 REGULATION OF CELL CYCLE PROCESS 13 558 0.0002657 0.002203
562 RESPONSE TO CYTOKINE 15 714 0.0002725 0.002256
563 ANATOMICAL STRUCTURE HOMEOSTASIS 9 285 0.0002785 0.002301
564 MYELOID LEUKOCYTE MEDIATED IMMUNITY 4 43 0.0002839 0.002338
565 CEREBRAL CORTEX CELL MIGRATION 4 43 0.0002839 0.002338
566 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 7 171 0.0002873 0.002362
567 REGULATION OF COLLATERAL SPROUTING 3 18 0.0002986 0.002442
568 MAST CELL MEDIATED IMMUNITY 3 18 0.0002986 0.002442
569 RESPONSE TO OXIDATIVE STRESS 10 352 0.0002986 0.002442
570 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 8 228 0.0003027 0.002466
571 TELENCEPHALON DEVELOPMENT 8 228 0.0003027 0.002466
572 RESPONSE TO BIOTIC STIMULUS 17 886 0.0003058 0.002488
573 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 4 44 0.0003105 0.002517
574 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 4 44 0.0003105 0.002517
575 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 8 229 0.0003117 0.002522
576 LEUKOCYTE DIFFERENTIATION 9 292 0.0003327 0.002687
577 LUNG MORPHOGENESIS 4 45 0.0003389 0.002718
578 POSITIVE REGULATION OF RECEPTOR ACTIVITY 4 45 0.0003389 0.002718
579 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 5 81 0.0003381 0.002718
580 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 5 81 0.0003381 0.002718
581 REGULATION OF LEUKOCYTE DIFFERENTIATION 8 232 0.0003401 0.002724
582 RESPONSE TO CORTICOSTEROID 7 176 0.0003422 0.002736
583 REGULATION OF CATABOLIC PROCESS 15 731 0.0003496 0.00279
584 REGULATION OF WOUND HEALING 6 126 0.0003524 0.002796
585 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 3 19 0.0003527 0.002796
586 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 3 19 0.0003527 0.002796
587 MACROPHAGE DIFFERENTIATION 3 19 0.0003527 0.002796
588 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 10 360 0.0003566 0.002822
589 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 6 127 0.0003677 0.002891
590 ICOSANOID BIOSYNTHETIC PROCESS 4 46 0.000369 0.002891
591 POSITIVE REGULATION OF BINDING 6 127 0.0003677 0.002891
592 PEPTIDYL THREONINE MODIFICATION 4 46 0.000369 0.002891
593 FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 4 46 0.000369 0.002891
594 REGULATION OF OSSIFICATION 7 178 0.0003663 0.002891
595 REGULATION OF ERBB SIGNALING PATHWAY 5 83 0.0003786 0.002951
596 HAIR CYCLE 5 83 0.0003786 0.002951
597 MOLTING CYCLE 5 83 0.0003786 0.002951
598 REGULATION OF APOPTOTIC SIGNALING PATHWAY 10 363 0.0003807 0.002962
599 NEGATIVE REGULATION OF MOLECULAR FUNCTION 19 1079 0.0003923 0.003047
600 REGULATION OF REPRODUCTIVE PROCESS 6 129 0.0003997 0.0031
601 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 4 47 0.000401 0.003105
602 REGULATION OF NEURON PROJECTION REGENERATION 3 20 0.0004127 0.00319
603 SENSORY ORGAN MORPHOGENESIS 8 239 0.0004146 0.003199
604 RESPONSE TO AMINE 4 48 0.000435 0.003329
605 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 48 0.000435 0.003329
606 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 4 48 0.000435 0.003329
607 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 6 131 0.0004339 0.003329
608 REGULATION OF MYELOID CELL DIFFERENTIATION 7 183 0.0004328 0.003329
609 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 6 132 0.0004518 0.003452
610 NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 5 87 0.0004706 0.003575
611 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 6 133 0.0004703 0.003575
612 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 4 49 0.000471 0.003575
613 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 6 133 0.0004703 0.003575
614 MAST CELL ACTIVATION 3 21 0.0004789 0.003629
615 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 6 134 0.0004894 0.003703
616 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 88 0.000496 0.003746
617 CELLULAR HOMEOSTASIS 14 676 0.0005051 0.003809
618 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 4 50 0.000509 0.003821
619 CELL GROWTH 6 135 0.0005091 0.003821
620 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.000509 0.003821
621 POSITIVE REGULATION OF CELL CYCLE PROCESS 8 247 0.0005155 0.003863
622 GLIAL CELL DIFFERENTIATION 6 136 0.0005294 0.00396
623 RESPONSE TO ALKALOID 6 137 0.0005503 0.004093
624 RESPONSE TO NICOTINE 4 51 0.0005492 0.004093
625 ACTIVATION OF PROTEIN KINASE B ACTIVITY 3 22 0.0005515 0.004093
626 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 3 22 0.0005515 0.004093
627 ERK1 AND ERK2 CASCADE 3 22 0.0005515 0.004093
628 REGULATION OF HEMOPOIESIS 9 314 0.0005627 0.004169
629 MITOTIC CELL CYCLE 15 766 0.0005689 0.004208
630 RESPONSE TO BACTERIUM 12 528 0.0005719 0.004224
631 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 4 52 0.0005915 0.004355
632 ACTIVATION OF MAPKK ACTIVITY 4 52 0.0005915 0.004355
633 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 5 92 0.0006081 0.00447
634 CONNECTIVE TISSUE DEVELOPMENT 7 194 0.0006129 0.004498
635 NON CANONICAL WNT SIGNALING PATHWAY 6 140 0.000617 0.004521
636 NEGATIVE REGULATION OF TRANSPORT 11 458 0.0006183 0.004524
637 SINGLE ORGANISM CELL ADHESION 11 459 0.0006296 0.004586
638 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 3 23 0.0006308 0.004586
639 LYSOSOME LOCALIZATION 3 23 0.0006308 0.004586
640 REGULATION OF METANEPHROS DEVELOPMENT 3 23 0.0006308 0.004586
641 REGULATION OF MUSCLE SYSTEM PROCESS 7 195 0.0006318 0.004586
642 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 4 53 0.0006362 0.004611
643 REGULATION OF PROTEIN SECRETION 10 389 0.0006517 0.004716
644 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 9 321 0.0006587 0.004759
645 POLYOL METABOLIC PROCESS 5 95 0.0007039 0.00507
646 REGULATION OF LIPID TRANSPORT 5 95 0.0007039 0.00507
647 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.000717 0.005149
648 REGULATION OF ANOIKIS 3 24 0.000717 0.005149
649 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 55 0.0007325 0.005252
650 REGULATION OF LEUKOCYTE CHEMOTAXIS 5 96 0.0007382 0.005284
651 NEURON NEURON SYNAPTIC TRANSMISSION 4 56 0.0007844 0.005598
652 FATTY ACID TRANSPORT 4 56 0.0007844 0.005598
653 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 3 25 0.0008104 0.005775
654 DIGESTIVE SYSTEM DEVELOPMENT 6 148 0.0008255 0.005864
655 POSITIVE REGULATION OF CELL GROWTH 6 148 0.0008255 0.005864
656 ENDOTHELIAL CELL MIGRATION 4 57 0.0008388 0.005949
657 NEURAL TUBE DEVELOPMENT 6 149 0.0008549 0.006055
658 REGULATION OF LEUKOCYTE PROLIFERATION 7 206 0.0008726 0.00617
659 LIMBIC SYSTEM DEVELOPMENT 5 100 0.000888 0.00627
660 NEGATIVE REGULATION OF WOUND HEALING 4 58 0.0008958 0.006315
661 DEVELOPMENTAL PROGRAMMED CELL DEATH 3 26 0.0009112 0.006385
662 NEGATIVE REGULATION OF LIPID TRANSPORT 3 26 0.0009112 0.006385
663 REGULATION OF P38MAPK CASCADE 3 26 0.0009112 0.006385
664 REGULATION OF CELL FATE COMMITMENT 3 26 0.0009112 0.006385
665 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 4 59 0.0009554 0.006675
666 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 4 59 0.0009554 0.006675
667 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 7 211 0.001003 0.007
668 POSITIVE REGULATION OF HEART GROWTH 3 27 0.00102 0.007059
669 REGULATION OF LAMELLIPODIUM ASSEMBLY 3 27 0.00102 0.007059
670 STEM CELL PROLIFERATION 4 60 0.001018 0.007059
671 REGULATION OF FATTY ACID TRANSPORT 3 27 0.00102 0.007059
672 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 3 27 0.00102 0.007059
673 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 7 213 0.00106 0.007329
674 REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 4 61 0.001083 0.007455
675 POSITIVE REGULATION OF LYASE ACTIVITY 4 61 0.001083 0.007455
676 NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 4 61 0.001083 0.007455
677 REGULATION OF NEUROBLAST PROLIFERATION 3 28 0.001136 0.007794
678 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 3 28 0.001136 0.007794
679 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 7 216 0.001149 0.007877
680 FOREBRAIN CELL MIGRATION 4 62 0.001151 0.007877
681 EPITHELIAL CELL DIFFERENTIATION 11 495 0.001163 0.007946
682 REGULATION OF MITOCHONDRION ORGANIZATION 7 218 0.001212 0.008271
683 ION HOMEOSTASIS 12 576 0.001214 0.008271
684 MUSCLE SYSTEM PROCESS 8 282 0.001217 0.008276
685 REGULATION OF OSTEOCLAST DIFFERENTIATION 4 63 0.001222 0.008302
686 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 3 29 0.00126 0.008496
687 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 3 29 0.00126 0.008496
688 POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 3 29 0.00126 0.008496
689 NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 3 29 0.00126 0.008496
690 NEUROBLAST PROLIFERATION 3 29 0.00126 0.008496
691 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 7 220 0.001278 0.008592
692 CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS 7 220 0.001278 0.008592
693 RESPONSE TO HYDROGEN PEROXIDE 5 109 0.001307 0.008774
694 POSITIVE REGULATION OF HEMOPOIESIS 6 163 0.001359 0.009098
695 REGULATION OF NUCLEAR DIVISION 6 163 0.001359 0.009098
696 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 65 0.001373 0.009182
697 NEGATIVE REGULATION OF CELL ADHESION 7 223 0.001381 0.00922
698 LEUKOCYTE DEGRANULATION 3 30 0.001392 0.009229
699 NEGATIVE REGULATION OF CELL MATRIX ADHESION 3 30 0.001392 0.009229
700 RESPONSE TO AMPHETAMINE 3 30 0.001392 0.009229
701 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 3 30 0.001392 0.009229
702 PHOSPHOLIPID CATABOLIC PROCESS 3 30 0.001392 0.009229
703 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 4 66 0.001454 0.009622
704 REGULATION OF OSTEOBLAST DIFFERENTIATION 5 112 0.001474 0.009744
705 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 6 166 0.001492 0.009844
NumGOOverlapSizeP ValueAdj. P Value
1 KINASE ACTIVITY 56 842 1.152e-38 1.07e-35
2 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 56 992 7.333e-35 3.406e-32
3 MOLECULAR FUNCTION REGULATOR 62 1353 9.208e-34 2.851e-31
4 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 32 228 6.518e-32 1.514e-29
5 PROTEIN KINASE ACTIVITY 44 640 1.657e-30 2.583e-28
6 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 22 70 1.668e-30 2.583e-28
7 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 33 303 3.321e-29 4.407e-27
8 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 20 64 9.564e-28 1.111e-25
9 PROTEIN TYROSINE KINASE ACTIVITY 26 176 1.386e-26 1.431e-24
10 RECEPTOR BINDING 56 1476 5.572e-26 5.176e-24
11 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 20 81 2.062e-25 1.741e-23
12 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 15 43 6.706e-22 4.876e-20
13 GROWTH FACTOR ACTIVITY 22 160 6.823e-22 4.876e-20
14 SIGNAL TRANSDUCER ACTIVITY 55 1731 9.209e-22 6.111e-20
15 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 15 51 1.342e-20 8.312e-19
16 RIBONUCLEOTIDE BINDING 52 1860 4.981e-18 2.892e-16
17 ENZYME BINDING 50 1737 8.335e-18 4.555e-16
18 RECEPTOR SIGNALING PROTEIN ACTIVITY 19 172 3.365e-17 1.737e-15
19 GROWTH FACTOR BINDING 17 123 3.572e-17 1.746e-15
20 PROTEIN TYROSINE KINASE BINDING 12 54 4.505e-15 2.093e-13
21 KINASE BINDING 28 606 6.817e-15 3.016e-13
22 ENZYME ACTIVATOR ACTIVITY 25 471 9.931e-15 4.193e-13
23 NEUROTROPHIN RECEPTOR BINDING 8 14 2.149e-14 8.679e-13
24 GROWTH FACTOR RECEPTOR BINDING 15 129 3.86e-14 1.494e-12
25 ADENYL NUCLEOTIDE BINDING 41 1514 1.392e-13 5.173e-12
26 PHOSPHOLIPASE ACTIVITY 13 94 2.106e-13 7.526e-12
27 ENZYME REGULATOR ACTIVITY 32 959 5.072e-13 1.745e-11
28 PHOSPHOLIPASE A2 ACTIVITY 9 31 9.134e-13 3.031e-11
29 LIPASE ACTIVITY 13 117 3.745e-12 1.2e-10
30 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 7 15 6.45e-12 1.997e-10
31 INSULIN RECEPTOR SUBSTRATE BINDING 6 11 6.646e-11 1.992e-09
32 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 11 92 8.055e-11 2.339e-09
33 PROTEIN SERINE THREONINE KINASE ACTIVITY 20 445 1.149e-10 3.235e-09
34 KINASE ACTIVATOR ACTIVITY 9 62 7.567e-10 2.068e-08
35 CHEMOATTRACTANT ACTIVITY 7 27 8.265e-10 2.194e-08
36 KINASE REGULATOR ACTIVITY 13 186 1.306e-09 3.37e-08
37 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 6 19 3.717e-09 9.332e-08
38 GTPASE ACTIVITY 14 246 4.275e-09 1.045e-07
39 HEPARIN BINDING 11 157 2.488e-08 5.927e-07
40 INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 5 15 5.866e-08 1.362e-06
41 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 6 30 7.606e-08 1.724e-06
42 INSULIN RECEPTOR BINDING 6 32 1.147e-07 2.522e-06
43 GTP DEPENDENT PROTEIN BINDING 5 17 1.194e-07 2.522e-06
44 CYTOKINE RECEPTOR BINDING 13 271 1.168e-07 2.522e-06
45 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 14 329 1.634e-07 3.373e-06
46 SULFUR COMPOUND BINDING 12 234 1.783e-07 3.601e-06
47 PROTEIN PHOSPHATASE BINDING 9 120 2.712e-07 5.36e-06
48 GLYCOSAMINOGLYCAN BINDING 11 205 3.767e-07 7.291e-06
49 CARBOXYLIC ESTER HYDROLASE ACTIVITY 9 135 7.379e-07 1.399e-05
50 EPHRIN RECEPTOR BINDING 5 24 7.869e-07 1.462e-05
51 PLATELET DERIVED GROWTH FACTOR BINDING 4 11 9.126e-07 1.662e-05
52 MAP KINASE KINASE ACTIVITY 4 12 1.361e-06 2.431e-05
53 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 5 28 1.777e-06 3.114e-05
54 PHOSPHATASE BINDING 9 162 3.368e-06 5.794e-05
55 PROTEIN COMPLEX BINDING 21 935 5.49e-06 9.273e-05
56 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 5 39 9.748e-06 0.0001617
57 PROTEIN DIMERIZATION ACTIVITY 23 1149 1.238e-05 0.0002018
58 SIGNALING ADAPTOR ACTIVITY 6 74 1.816e-05 0.0002909
59 FIBROBLAST GROWTH FACTOR BINDING 4 23 2.285e-05 0.0003598
60 PROTEIN HOMODIMERIZATION ACTIVITY 17 722 2.563e-05 0.0003968
61 IDENTICAL PROTEIN BINDING 23 1209 2.774e-05 0.0004225
62 GUANYL NUCLEOTIDE BINDING 12 390 3.439e-05 0.0005153
63 PROTEIN HETERODIMERIZATION ACTIVITY 13 468 4.635e-05 0.0006835
64 DIACYLGLYCEROL BINDING 3 11 6.273e-05 0.0009105
65 GTPASE BINDING 10 295 7.112e-05 0.001016
66 LIPID BINDING 15 657 0.0001107 0.001558
67 MAP KINASE ACTIVITY 3 14 0.0001361 0.00186
68 THIOESTERASE BINDING 3 14 0.0001361 0.00186
69 GLUTAMATE RECEPTOR BINDING 4 37 0.0001573 0.002117
70 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 3 16 0.0002072 0.00275
71 PROTEIN DOMAIN SPECIFIC BINDING 14 624 0.0002261 0.002959
72 SIGNALING RECEPTOR ACTIVITY 23 1393 0.0002339 0.003018
73 MACROMOLECULAR COMPLEX BINDING 23 1399 0.0002489 0.003167
74 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 5 77 0.000267 0.003351
75 PHOSPHOLIPASE BINDING 3 19 0.0003527 0.004312
76 EPHRIN RECEPTOR ACTIVITY 3 19 0.0003527 0.004312
77 HYDROLASE ACTIVITY ACTING ON ESTER BONDS 15 739 0.0003919 0.004728
78 RECEPTOR ACTIVITY 25 1649 0.0004454 0.005305
79 GDP BINDING 4 51 0.0005492 0.006458
80 CALCIUM ION BINDING 14 697 0.0006816 0.007915
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOPLASMIC SIDE OF MEMBRANE 21 170 6.143e-20 3.587e-17
2 SIDE OF MEMBRANE 24 428 1.074e-14 3.135e-12
3 INTRINSIC COMPONENT OF THE CYTOPLASMIC SIDE OF THE PLASMA MEMBRANE 8 15 4.576e-14 8.907e-12
4 EXTRINSIC COMPONENT OF MEMBRANE 17 252 5.785e-12 8.446e-10
5 INTRACELLULAR VESICLE 32 1259 5.909e-10 6.901e-08
6 INTRINSIC COMPONENT OF PLASMA MEMBRANE 36 1649 2.481e-09 2.217e-07
7 HETEROTRIMERIC G PROTEIN COMPLEX 7 32 3.037e-09 2.217e-07
8 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 10 98 2.911e-09 2.217e-07
9 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 6 20 5.277e-09 3.229e-07
10 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 11 136 5.53e-09 3.229e-07
11 VESICLE LUMEN 9 106 9.297e-08 4.936e-06
12 PLATELET ALPHA GRANULE LUMEN 7 55 1.589e-07 7.731e-06
13 CELL SUBSTRATE JUNCTION 15 398 2.772e-07 1.245e-05
14 GOLGI APPARATUS 29 1445 7.069e-07 2.949e-05
15 CELL SURFACE 20 757 8.109e-07 3.157e-05
16 CELL JUNCTION 25 1151 1.147e-06 4.185e-05
17 PLATELET ALPHA GRANULE 7 75 1.373e-06 4.221e-05
18 PERINUCLEAR REGION OF CYTOPLASM 18 642 1.308e-06 4.221e-05
19 PLASMA MEMBRANE REGION 22 929 1.35e-06 4.221e-05
20 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 11 237 1.576e-06 4.603e-05
21 VACUOLE 25 1180 1.796e-06 4.996e-05
22 MEMBRANE REGION 24 1134 3.033e-06 8.05e-05
23 SECRETORY GRANULE LUMEN 7 85 3.211e-06 8.154e-05
24 ANCHORING JUNCTION 15 489 3.604e-06 8.77e-05
25 SECRETORY VESICLE 14 461 8.666e-06 0.0002024
26 CELL LEADING EDGE 12 350 1.184e-05 0.000266
27 SECRETORY GRANULE 12 352 1.254e-05 0.0002711
28 ACTIN FILAMENT 6 70 1.317e-05 0.0002747
29 MEMBRANE PROTEIN COMPLEX 21 1020 2.042e-05 0.0004111
30 RUFFLE 8 156 2.142e-05 0.0004171
31 PLASMA MEMBRANE PROTEIN COMPLEX 14 510 2.667e-05 0.0005024
32 RUFFLE MEMBRANE 6 80 2.84e-05 0.0005184
33 CELL PROJECTION 29 1786 4.265e-05 0.0007549
34 LEADING EDGE MEMBRANE 7 134 6.317e-05 0.001085
35 EXTRACELLULAR SPACE 24 1376 7.262e-05 0.001212
36 SITE OF POLARIZED GROWTH 7 149 0.0001231 0.001997
37 ENDOPLASMIC RETICULUM 26 1631 0.000153 0.002415
38 CELL PROJECTION PART 18 946 0.0002232 0.003431
39 CATALYTIC COMPLEX 19 1038 0.0002419 0.003623
40 ENDOSOME 16 793 0.0002664 0.00389
41 MEMBRANE MICRODOMAIN 9 288 0.0003007 0.004283
42 NEURON PART 21 1265 0.0004181 0.005813
43 MAST CELL GRANULE 3 21 0.0004789 0.006504
44 CYTOPLASMIC VESICLE PART 13 601 0.0005371 0.007129
45 PROTEIN KINASE COMPLEX 5 90 0.0005499 0.007136
46 RECEPTOR COMPLEX 9 327 0.0007512 0.009537

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04014_Ras_signaling_pathway 148 236 3.27699999999972e-312 5.89899999999997e-310
2 hsa04151_PI3K_AKT_signaling_pathway 77 351 7.085e-97 6.377e-95
3 hsa04010_MAPK_signaling_pathway 65 268 1.442e-83 8.652e-82
4 hsa04510_Focal_adhesion 45 200 4.829e-55 2.173e-53
5 hsa04664_Fc_epsilon_RI_signaling_pathway 34 79 1.186e-52 4.271e-51
6 hsa04012_ErbB_signaling_pathway 33 87 8.113e-49 2.434e-47
7 hsa04810_Regulation_of_actin_cytoskeleton 42 214 1.551e-48 3.989e-47
8 hsa04370_VEGF_signaling_pathway 31 76 4.552e-47 1.024e-45
9 hsa04722_Neurotrophin_signaling_pathway 35 127 4.842e-46 9.683e-45
10 hsa04062_Chemokine_signaling_pathway 37 189 1.345e-42 2.422e-41
11 hsa04912_GnRH_signaling_pathway 28 101 6.557e-37 1.073e-35
12 hsa04662_B_cell_receptor_signaling_pathway 23 75 1.426e-31 2.139e-30
13 hsa04910_Insulin_signaling_pathway 27 138 4.497e-31 6.227e-30
14 hsa04660_T_cell_receptor_signaling_pathway 25 108 8.412e-31 1.081e-29
15 hsa04650_Natural_killer_cell_mediated_cytotoxicity 26 136 1.169e-29 1.403e-28
16 hsa04666_Fc_gamma_R.mediated_phagocytosis 21 95 1.592e-25 1.791e-24
17 hsa04730_Long.term_depression 18 70 2.555e-23 2.705e-22
18 hsa04540_Gap_junction 18 90 3.688e-21 3.688e-20
19 hsa04914_Progesterone.mediated_oocyte_maturation 17 87 7.421e-20 7.03e-19
20 hsa04380_Osteoclast_differentiation 19 128 1.109e-19 9.978e-19
21 hsa04620_Toll.like_receptor_signaling_pathway 17 102 1.311e-18 1.124e-17
22 hsa04210_Apoptosis 16 89 3.927e-18 3.213e-17
23 hsa04270_Vascular_smooth_muscle_contraction 17 116 1.28e-17 1.002e-16
24 hsa04360_Axon_guidance 17 130 9.352e-17 7.014e-16
25 hsa00565_Ether_lipid_metabolism 11 36 1.281e-15 9.226e-15
26 hsa00592_alpha.Linolenic_acid_metabolism 9 20 8.154e-15 5.645e-14
27 hsa04960_Aldosterone.regulated_sodium_reabsorption 11 42 8.791e-15 5.861e-14
28 hsa04150_mTOR_signaling_pathway 11 52 1.165e-13 7.488e-13
29 hsa04720_Long.term_potentiation 12 70 1.263e-13 7.841e-13
30 hsa04070_Phosphatidylinositol_signaling_system 12 78 4.903e-13 2.942e-12
31 hsa04916_Melanogenesis 13 101 5.461e-13 3.171e-12
32 hsa00591_Linoleic_acid_metabolism 9 30 6.523e-13 3.669e-12
33 hsa04670_Leukocyte_transendothelial_migration 13 117 3.745e-12 2.043e-11
34 hsa04972_Pancreatic_secretion 12 101 1.164e-11 6.163e-11
35 hsa00564_Glycerophospholipid_metabolism 11 80 1.694e-11 8.71e-11
36 hsa04973_Carbohydrate_digestion_and_absorption 9 44 2.96e-11 1.455e-10
37 hsa04144_Endocytosis 15 203 2.991e-11 1.455e-10
38 hsa04975_Fat_digestion_and_absorption 9 46 4.543e-11 2.152e-10
39 hsa04320_Dorso.ventral_axis_formation 7 25 4.529e-10 2.09e-09
40 hsa00590_Arachidonic_acid_metabolism 9 59 4.776e-10 2.149e-09
41 hsa04920_Adipocytokine_signaling_pathway 9 68 1.77e-09 7.724e-09
42 hsa04630_Jak.STAT_signaling_pathway 12 155 1.802e-09 7.724e-09
43 hsa04020_Calcium_signaling_pathway 12 177 8.154e-09 3.413e-08
44 hsa04520_Adherens_junction 8 73 6.657e-08 2.723e-07
45 hsa04310_Wnt_signaling_pathway 10 151 1.866e-07 7.463e-07
46 hsa04530_Tight_junction 9 133 6.506e-07 2.546e-06
47 hsa04621_NOD.like_receptor_signaling_pathway 6 59 4.838e-06 1.853e-05
48 hsa04622_RIG.I.like_receptor_signaling_pathway 6 71 1.43e-05 5.362e-05
49 hsa04971_Gastric_acid_secretion 6 74 1.816e-05 6.671e-05
50 hsa04114_Oocyte_meiosis 7 114 2.239e-05 8.062e-05
51 hsa04970_Salivary_secretion 6 89 5.201e-05 0.0001836
52 hsa00562_Inositol_phosphate_metabolism 5 57 6.37e-05 0.0002205
53 hsa04744_Phototransduction 3 29 0.00126 0.004279
54 hsa04640_Hematopoietic_cell_lineage 4 88 0.00415 0.01378
55 hsa04962_Vasopressin.regulated_water_reabsorption 3 44 0.004212 0.01378
56 hsa04742_Taste_transduction 3 52 0.006733 0.02164
57 hsa04623_Cytosolic_DNA.sensing_pathway 3 56 0.008266 0.0261
58 hsa04340_Hedgehog_signaling_pathway 2 56 0.06463 0.2006
59 hsa04976_Bile_secretion 2 71 0.09718 0.2965
60 hsa04141_Protein_processing_in_endoplasmic_reticulum 3 168 0.1287 0.386
61 hsa04390_Hippo_signaling_pathway 2 154 0.3158 0.9244
62 hsa04145_Phagosome 2 156 0.3212 0.9244
63 hsa04740_Olfactory_transduction 4 388 0.3235 0.9244

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

HCG11

 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-421;hsa-miR-618 10 NTRK2 Sponge network -0.781 0 -2.305 0 0.582
2

HCG11

 hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-502-3p;hsa-miR-93-5p 10 AKT3 Sponge network -0.781 0 -0.659 0.00047 0.574
3 DHRS4-AS1 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-582-5p;hsa-miR-589-3p 10 PIK3R1 Sponge network -0.646 0.01829 -0.892 0 0.557
4

RP11-175O19.4

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c 10 ABL2 Sponge network 0.743 0 0.604 0 0.55
5 MAGI2-AS3 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30d-5p;hsa-miR-339-5p;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-93-5p 12 RGL1 Sponge network -1.801 0 -0.974 0 0.532
6

LINC00261

 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-188-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-330-3p;hsa-miR-629-3p 11 PIK3R1 Sponge network -1.194 0 -0.892 0 0.513
7

RP11-12A2.3

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-93-5p 12 PIK3R1 Sponge network -4.779 0 -0.892 0 0.489
8

AC005562.1

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c 11 ABL2 Sponge network 1.127 0 0.604 0 0.484
9

TUG1

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 10 ABL2 Sponge network 0.972 0 0.604 0 0.48
10 LINC01018 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-338-5p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-93-5p 15 PIK3R1 Sponge network -3.231 0 -0.892 0 0.472
11 LDLRAD4-AS1 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-93-5p 10 PIK3R1 Sponge network -3.366 0 -0.892 0 0.45
12 RP11-43F13.3 hsa-miR-122-5p;hsa-miR-1269a;hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-204-5p;hsa-miR-365a-3p;hsa-miR-500a-3p 11 IGF1R Sponge network -1.507 0.01021 -0.705 0.00354 0.423
13 RP11-119D9.1 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p;hsa-miR-93-5p 11 PIK3R1 Sponge network -2.765 0 -0.892 0 0.418
14

FAM225B

 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-204-5p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-455-5p 11 IGF1R Sponge network 0.684 0.04717 -0.705 0.00354 0.406
15 RP11-563J2.2 hsa-miR-122-5p;hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-204-5p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-378c 10 IGF1R Sponge network -0.257 0.57019 -0.705 0.00354 0.402
16 RP11-290F5.1 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p 11 PIK3R1 Sponge network -1.679 5.0E-5 -0.892 0 0.402
17 RP11-121C2.2 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 10 ABL2 Sponge network 1.286 0 0.604 0 0.396
18

PTOV1-AS1

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 11 ABL2 Sponge network 1.252 0 0.604 0 0.395
19

HCG18

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 12 ABL2 Sponge network 1.42 0 0.604 0 0.393
20

AP006222.2

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-576-5p 10 ABL2 Sponge network 1.709 0 0.604 0 0.39
21 CTD-2015G9.2 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-204-5p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-616-5p;hsa-miR-99a-5p 12 IGF1R Sponge network 1.826 0.00897 -0.705 0.00354 0.389
22

KB-1572G7.2

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c 10 ABL2 Sponge network 2.124 0 0.604 0 0.381
23

RP11-747H7.3

 hsa-miR-122-5p;hsa-miR-1269a;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-204-5p;hsa-miR-33a-3p;hsa-miR-34a-5p;hsa-miR-374a-5p;hsa-miR-378a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-616-5p 14 IGF1R Sponge network 0.351 0.40524 -0.705 0.00354 0.38
24 AC025335.1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p 12 KSR2 Sponge network 1.297 0 0.507 0.11076 0.378
25 LINC00883 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193a-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-33a-3p;hsa-miR-365a-3p;hsa-miR-378a-3p;hsa-miR-378c 10 IGF1R Sponge network 0.72 0.01612 -0.705 0.00354 0.371
26 LINC00238 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p 12 PIK3R1 Sponge network -4.997 0 -0.892 0 0.369
27

LINC00261

 hsa-let-7e-5p;hsa-let-7i-5p;hsa-miR-140-3p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-21-5p;hsa-miR-27a-3p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-501-5p 13 INSR Sponge network -1.194 0 -0.278 0.00786 0.366
28

AP001469.9

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-576-5p 10 ABL2 Sponge network 2.428 0 0.604 0 0.365
29

GUSBP11

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c 11 ABL2 Sponge network 2.066 0 0.604 0 0.364
30

BAIAP2-AS1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-29a-3p;hsa-miR-29c-3p 11 KSR2 Sponge network 1.249 0 0.507 0.11076 0.363
31

AC004862.6

 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p;hsa-miR-93-5p 12 PIK3R1 Sponge network -2.202 0.00081 -0.892 0 0.357
32 FOXD2-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 11 KSR2 Sponge network 2.209 0 0.507 0.11076 0.354
33

AC005154.6

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 10 ABL2 Sponge network 1.75 0 0.604 0 0.343
34 CTC-559E9.6 hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 11 KSR2 Sponge network 1.336 0 0.507 0.11076 0.341
35

FAM225B

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-618 16 KSR2 Sponge network 0.684 0.04717 0.507 0.11076 0.339
36

MIR4435-1HG

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-576-5p 10 ABL2 Sponge network 2.541 0 0.604 0 0.338
37

KB-1572G7.2

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 15 KSR2 Sponge network 2.124 0 0.507 0.11076 0.337
38 LINC00342 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-618 15 KSR2 Sponge network 1.503 0 0.507 0.11076 0.335
39

TUG1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 14 KSR2 Sponge network 0.972 0 0.507 0.11076 0.334
40

RP11-12A2.3

 hsa-miR-103a-2-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-25-3p;hsa-miR-30d-5p;hsa-miR-339-5p;hsa-miR-92a-3p;hsa-miR-93-5p 11 RGL1 Sponge network -4.779 0 -0.974 0 0.332
41 LOXL1-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-30b-3p 11 KSR2 Sponge network 0.356 0.41037 0.507 0.11076 0.327
42

SNHG17

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 11 ABL2 Sponge network 1.214 0 0.604 0 0.326
43 RP11-407B7.1 hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-338-5p;hsa-miR-629-3p;hsa-miR-93-5p 10 PIK3R1 Sponge network -0.818 0.00584 -0.892 0 0.324
44

GUSBP11

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 15 KSR2 Sponge network 2.066 0 0.507 0.11076 0.323
45

RP11-166D19.1

 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-324-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p 11 PIK3R1 Sponge network -0.244 0.28835 -0.892 0 0.32
46 RP11-479G22.8 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p 10 KSR2 Sponge network 1.511 0 0.507 0.11076 0.32
47

AC005562.1

 hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-194-3p;hsa-miR-28-5p;hsa-miR-30e-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-378c;hsa-miR-455-5p 10 KSR1 Sponge network 1.127 0 0.643 0 0.32
48

AP001258.4

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-30b-3p 12 KSR2 Sponge network 1.249 0 0.507 0.11076 0.317
49 RP5-1074L1.4 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p 13 KSR2 Sponge network 2.302 0 0.507 0.11076 0.311
50

CTBP1-AS2

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c 10 ABL2 Sponge network 1.419 0 0.604 0 0.31
51 SNHG11 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30e-5p 11 KSR2 Sponge network 1.239 0 0.507 0.11076 0.309
52

LINC00665

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 15 KSR2 Sponge network 2.394 0 0.507 0.11076 0.309
53

SNHG14

 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193a-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-378a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-455-5p;hsa-miR-885-5p 11 IGF1R Sponge network 0.608 0.02834 -0.705 0.00354 0.309
54 TOB1-AS1 hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-150-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-218-5p;hsa-miR-2355-3p;hsa-miR-330-3p;hsa-miR-450b-5p 10 PRKCA Sponge network 0.811 0 0.663 0 0.308
55

LINC00654

 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-33a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-885-5p;hsa-miR-99a-5p 10 IGF1R Sponge network 0.697 0.02064 -0.705 0.00354 0.308
56 RP11-95D17.1 hsa-miR-101-3p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p 11 KSR2 Sponge network 0.96 0 0.507 0.11076 0.308
57 MAPKAPK5-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 15 KSR2 Sponge network 1.411 0 0.507 0.11076 0.307
58 RP11-1C1.4 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 10 KSR2 Sponge network 0.709 0.31229 0.507 0.11076 0.304
59

AC005562.1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 15 KSR2 Sponge network 1.127 0 0.507 0.11076 0.304
60

DYNLL1-AS1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 11 KSR2 Sponge network 1.231 0 0.507 0.11076 0.298
61 KB-1572G7.3 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-30b-3p 11 KSR2 Sponge network 2.031 0 0.507 0.11076 0.298
62 CTD-2020K17.1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-30b-3p 11 KSR2 Sponge network 0.8 0.0101 0.507 0.11076 0.298
63

RP11-403I13.8

 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-204-5p;hsa-miR-33a-3p;hsa-miR-365a-3p;hsa-miR-378a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-885-5p 12 IGF1R Sponge network 0.602 0.00406 -0.705 0.00354 0.297
64 LINC00205 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 11 KSR2 Sponge network 1.978 0 0.507 0.11076 0.296
65

MIAT

 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193a-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-455-5p 11 IGF1R Sponge network 1.039 0.0004 -0.705 0.00354 0.292
66 SNHG1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 14 KSR2 Sponge network 2.013 0 0.507 0.11076 0.291
67 AC159540.1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-618 15 KSR2 Sponge network 2.112 0 0.507 0.11076 0.287
68 RP11-488L18.10 hsa-miR-101-3p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 11 KSR2 Sponge network 1.599 0 0.507 0.11076 0.286
69 AC159540.2 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 13 KSR2 Sponge network 2.249 0 0.507 0.11076 0.285
70

FAM83H-AS1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29c-3p 12 KSR2 Sponge network 1.49 0 0.507 0.11076 0.284
71 LINC01057 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-618 12 KSR2 Sponge network 1.427 3.0E-5 0.507 0.11076 0.28
72

RP5-1120P11.1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p 12 KSR2 Sponge network 3.942 0 0.507 0.11076 0.279
73

PTOV1-AS1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 15 KSR2 Sponge network 1.252 0 0.507 0.11076 0.277
74

SNHG12

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 14 KSR2 Sponge network 1.791 0 0.507 0.11076 0.277
75

RP11-133K1.6

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p;hsa-miR-576-5p 10 ABL2 Sponge network 1.056 0 0.604 0 0.274
76

TPT1-AS1

 hsa-miR-122-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193a-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-378a-5p;hsa-miR-378c;hsa-miR-455-5p 11 IGF1R Sponge network 0.45 2.0E-5 -0.705 0.00354 0.273
77

RP11-600F24.7

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30e-5p 14 KSR2 Sponge network 2.603 0 0.507 0.11076 0.273
78

RP11-166D19.1

 hsa-miR-130b-3p;hsa-miR-151a-5p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-361-5p;hsa-miR-421;hsa-miR-532-5p;hsa-miR-590-5p;hsa-miR-618 10 NTRK2 Sponge network -0.244 0.28835 -2.305 0 0.271
79 RP11-7F17.3 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p 11 PIK3R1 Sponge network -0.873 0.00204 -0.892 0 0.271
80 CTD-3162L10.1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 14 KSR2 Sponge network 3.111 0 0.507 0.11076 0.27
81 SMIM2-AS1 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p 12 PIK3R1 Sponge network -0.66 0.00587 -0.892 0 0.27
82 AC073283.4 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-193b-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 11 KSR2 Sponge network 1.514 0 0.507 0.11076 0.27
83 EIF3J-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 13 KSR2 Sponge network 0.894 0 0.507 0.11076 0.269
84 RP5-1085F17.3 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30e-5p 13 KSR2 Sponge network 0.983 0 0.507 0.11076 0.269
85 PCED1B-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-30b-3p 11 KSR2 Sponge network 0.462 0.05063 0.507 0.11076 0.269
86 LENG8-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 10 KSR2 Sponge network 2.17 0 0.507 0.11076 0.268
87 AC017104.6 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 10 KSR2 Sponge network 1.175 0.00784 0.507 0.11076 0.266
88 AC013275.2 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-29c-3p 11 KSR2 Sponge network 1.388 0.00681 0.507 0.11076 0.265
89

RP11-540A21.2

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c 10 ABL2 Sponge network 1.758 0 0.604 0 0.264
90 MATN1-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30b-3p 11 KSR2 Sponge network 1.031 0 0.507 0.11076 0.264
91 RP11-378A13.1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 10 KSR2 Sponge network 0.433 0.00069 0.507 0.11076 0.263
92 LINC00152 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30e-5p 14 KSR2 Sponge network 2.553 0 0.507 0.11076 0.262
93 AC074289.1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-30b-3p 11 KSR2 Sponge network 0.704 0.00177 0.507 0.11076 0.262
94

RP11-600F24.7

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 11 ABL2 Sponge network 2.603 0 0.604 0 0.26
95

RP11-403I13.8

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29c-3p;hsa-miR-30b-3p;hsa-miR-30e-5p 13 KSR2 Sponge network 0.602 0.00406 0.507 0.11076 0.26
96

RP1-239B22.5

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-30b-3p 12 KSR2 Sponge network 0.922 0.00414 0.507 0.11076 0.259
97 RP11-23P13.6 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29c-3p;hsa-miR-30b-3p 11 KSR2 Sponge network 1.097 0 0.507 0.11076 0.259
98

TPT1-AS1

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30e-5p 13 KSR2 Sponge network 0.45 2.0E-5 0.507 0.11076 0.258
99

RP5-1120P11.1

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c 10 ABL2 Sponge network 3.942 0 0.604 0 0.256
100 MAFG-AS1 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p 12 KSR2 Sponge network 2.966 0 0.507 0.11076 0.256
101 CTD-2008L17.2 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-193b-5p;hsa-miR-194-5p;hsa-miR-29c-3p;hsa-miR-30b-3p 10 KSR2 Sponge network 2.352 0.00138 0.507 0.11076 0.256
102 RP5-882C2.2 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p 10 KSR2 Sponge network 1.879 0 0.507 0.11076 0.255
103

CTC-459F4.3

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-505-3p 10 ABL2 Sponge network 1.207 0 0.604 0 0.252
104

BAIAP2-AS1

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-576-5p 11 ABL2 Sponge network 1.249 0 0.604 0 0.251
105

TPT1-AS1

 hsa-let-7g-3p;hsa-miR-125b-5p;hsa-miR-139-5p;hsa-miR-192-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c 10 ABL2 Sponge network 0.45 2.0E-5 0.604 0 0.251
106

SNHG17

 hsa-miR-101-3p;hsa-miR-122-5p;hsa-miR-125b-2-3p;hsa-miR-126-5p;hsa-miR-139-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-192-5p;hsa-miR-193b-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-29a-3p;hsa-miR-29c-3p;hsa-miR-30e-5p 14 KSR2 Sponge network 1.214 0 0.507 0.11076 0.251

Quest ID: a73eb144e819fe575e09f2f5ccaa5270